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SUMMARY
Actinobacteria are Gram-positive bacteria with high GC DNA
content that constitute one of the largest bacterial phyla, and they
are ubiquitously distributed in both aquatic and terrestrial ecosys-
tems. Many Actinobacteria have a mycelial lifestyle and undergo
complex morphological differentiation. They also have an exten-
sive secondary metabolism and produce about two-thirds of all
naturally derived antibiotics in current clinical use, as well as
many anticancer, anthelmintic, and antifungal compounds. Con-
sequently, these bacteria are of major importance for biotechnol-
ogy,medicine, and agriculture.Actinobacteria play diverse roles in
their associationswith various higher organisms, since theirmem-
bers have adopted different lifestyles, and the phylum includes
pathogens (notably, species of Corynebacterium, Mycobacterium,
Nocardia, Propionibacterium, and Tropheryma), soil inhabitants
(e.g., Micromonospora and Streptomyces species), plant commen-
sals (e.g., Frankia spp.), and gastrointestinal commensals (Bifido-
bacterium spp.). Actinobacteria also play an important role as
symbionts and as pathogens in plant-associated microbial com-
munities. This review presents an update on the biology of this
important bacterial phylum.
INTRODUCTION
The phylumActinobacteria is one of the largest taxonomic unitsamong the major lineages currently recognized within the
Bacteria domain (1). The actinobacterial genomes sequenced to
date belong to organisms relevant to human and veterinary med-
icine, biotechnology, and ecology, and their observed genomic
heterogeneity is assumed to reflect their biodiversity (2). The ma-
jority of the Actinobacteria are free-living organisms that are
widely distributed in both terrestrial and aquatic (including ma-
rine) ecosystems (3). Actinobacteria are Gram-positive filamen-
tous bacteria with a high guanine-plus-cytosine (GC) content in
their genomes. They grow by a combination of tip extension and
branching of the hyphae. This is what gave them their name,
which derives from the Greek words for ray (aktis or aktin) and
fungi (mukes). Traditionally, actinomycetes were considered
transitional forms between fungi and bacteria. Indeed, like fila-
mentous fungi, many Actinobacteria produce a mycelium, and
many of these mycelial actinomycetes reproduce by sporulation.
However, the comparison to fungi is only superficial: like all bac-
teria, actinomycetes’ cells are thin with a chromosome that is or-
ganized in a prokaryotic nucleoid and a peptidoglycan cell wall;
furthermore, the cells are susceptible to antibacterial agents (Fig.
1). Physiologically and ecologically, most Actinobacteria are aero-
bic, but there are exceptions. Further, they can be heterotrophic or
chemoautotrophic, but most are chemoheterotrophic and able to
use a wide variety of nutritional sources, including various com-
plex polysaccharides (4, 5). Actinobacteria may be inhabitants of
soil or aquatic environments (e.g., Streptomyces,Micromonospora,
Rhodococcus, and Salinispora species), plant symbionts (e.g.,
Frankia spp.), plant or animal pathogens (e.g., Corynebacterium,
Mycobacterium, or Nocardia species), or gastrointestinal com-
mensals (e.g., Bifidobacterium spp.).
BIOLOGY OF ACTINOBACTERIA
Most of the Actinobacteria (the streptomycetes in particular) are
saprophytic, soil-dwelling organisms that spend the majority of
their life cycles as semidormant spores, especially under nutrient-
limited conditions (6). However, the phylum has adapted to a
wide range of ecological environments: actinomycetes are also
present in soils, fresh and salt water, and the air. They are more
abundant in soils than other media, especially in alkaline soils
and soils rich in organic matter, where they constitute an im-
portant part of the microbial population. Actinobacteria can be
found both on the soil surface and at depths of more than 2 m
below ground (7).
The population density of Actinobacteria depends on their
habitat and the prevailing climate conditions. They are typically
present at densities on the order of 106 to 109 cells per gram of soil
(7); soil populations are dominated by the genus Streptomyces,
which accounts for over 95% of the Actinomycetales strains iso-
lated from soil (8). Other factors, such as temperature, pH, and
soil moisture, also influence the growth of Actinobacteria. Like
other soil bacteria, Actinobacteria are mostly mesophilic, with op-
timal growth at temperatures between 25 and 30°C. However,
thermophilic Actinobacteria can grow at temperatures ranging
from50 to 60°C (9). Vegetative growth ofActinobacteria in the soil
is favored by low humidity, especially when the spores are sub-
merged inwater. In dry soils where themoisture tension is greater,
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growth is very limited and may be halted. Most Actinobacteria
grow in soils with a neutral pH. They grow best at a pH between 6
and 9, with maximum growth around neutrality. However, a few
strains of Streptomyces have been isolated from acidic soils (pH
3.5) (10). The first study on the effect of climate on the distribu-
tion of Actinobacteriawas done by Hiltner and Strömer (11), who
showed that these bacteria account for 20% of the microbial flora
of the soil in spring and more than 30% in the autumn because of
the large amounts of crop residues available at this time of year.
However, during the winter, frost reduces their relative abun-
dance to only 13%.
Taxonomy of Actinobacteria
Actinobacteria represent one of the largest taxonomic units among
the 18 major lineages currently recognized within the Bacteria
domain, including 5 subclasses, 6 orders, and 14 suborders (1).
The genera of this phylum exhibit enormous diversity in terms of
their morphology, physiology, and metabolic capabilities. The
taxonomy of Actinobacteria has evolved significantly over time
with the accumulation of knowledge. The order Actinomycetales,
established by Buchanan in 1917 (12), belongs to this group of
prokaryotic organisms.
The phylum Actinobacteria is delineated on the basis of its
branching position in 16S rRNA gene trees. However, rRNA se-
quences do not discriminate well between closely related species
or even genera, which can create ambiguity. For instance, the tax-
onomic status of the genus Kitasatospora (13) within the family
Streptomycetaceae has been disputed for many years (1, 14, 15),
although a recent detailed genetic analysis provided strong evi-
dence that it should be regarded as a separate genus (16). A similar
close relationship exists betweenMicromonospora,Verrucosispora,
and Salinispora. Additional genetic markers have therefore been
used to discriminate between closely related genera, including
rpoB and, most recently, ssgB, which is particularly useful for dis-
criminating between closely related genera (17). Moreover, the
massive recent increase in the availability of genome sequence
information has provided detailed insights into genome evolution
and made it possible to identify genes specific to organisms at the
level of genera and family (18).
An updated taxonomy of the phylum Actinobacteria that is
based on 16S rRNA trees was recently reported (1). That update
eliminated the taxonomic ranks of subclasses and suborders, ele-
vating the former subclasses and suborders to the ranks of classes
and orders, respectively (19). The phylum is thus divided into six
classes: Actinobacteria, Acidimicrobiia, Coriobacteriia, Nitrilirup-
toria, Rubrobacteria, and Thermoleophilia.
The class Actinobacteria contains 16 orders, including both of
the previously proposed orders, Actinomycetales and Bifidobacte-
riales (20). The order Actinomycetales is now restricted to the
members of the family Actinomycetaceae, and the other suborders
that were previously part of this order are now designated distinct
orders (19). Consequently, 43 of the 53 families within the phylum
Actinobacteria are assigned to a single class, Actinobacteria, whereas
the other five classes together contain only 10 families (21).
Morphological classification. The main characteristics used to
delineate the taxonomy of Actinobacteria at the genus and species
levels aremicroscopicmorphology and chemotaxonomy. The lat-
ter of these characteristics primarily relates to the composition of
the cell wall and the whole-cell sugar distribution, although phos-
pholipid composition andmenaquinone typemay also be consid-
ered for fine-tuning purposes (22).
FIG 1 Schematic representation of the life cycle of sporulating actinomycetes.
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Mycelial fragmentation can be regarded as a special form of
vegetative reproduction. However, the Actinobacteria with pri-
marily mycelial lifestyles usually reproduce by forming asexual
spores. Actinobacteria exhibit a wide variety of morphologies, dif-
feringmainlywith respect to the presence or absence of a substrate
mycelium or aerial mycelium, the color of the mycelium, the pro-
duction of diffusible melanoid pigments, and the structure and
appearance of their spores (Fig. 1).
(i) Mycelial morphology. Except for Sporichthya sp., which
produces aerial hyphae that are initiated upright on the surface of
the medium by holdfasts, Actinobacteria form a substrate myce-
lium in both submerged and solid-grown cultures. However, on
solid surfaces, many differentiate to form aerial hyphae, whose
main purpose is to produce reproductive spores (23, 24). The
substrate mycelium develops from outgrowth of a germinating
spore. The branching substrate mycelium is often monopodial,
but in some rare cases,Actinobacteria, such asThermoactinomyces,
exhibit dichotomous branching (25). On the other hand, mem-
bers of theMicromonosporaceae family produce an extensive sub-
strate mycelium with an absent or rudimentary aerial mycelium.
Actinobacteria exhibit a wide variety of morphologies, includ-
ing coccoid (Micrococcus) and rod-coccoid (Arthrobacter), as well
as fragmenting hyphal forms (Nocardia spp.) and also forms with
permanent and highly differentiated branched mycelia (e.g.,
Streptomyces spp., Frankia) (26). Rhodococci form elongated fil-
aments on the substrate and do not produce a truemycelium (27),
while corynebacteria do not producemycelia at all. However, as in
other Actinobacteria, the filaments grow at the apex instead of by
lateral wall extension (28, 29). Actinobacteria belonging to the ge-
nusOerskovia are characterized by the formation of branched sub-
strate hyphae that break up into flagellated motile elements (30).
Further, mycobacteria and rhodococci do not usually form aerial
hyphae, although some exceptions exist (31).
(ii) Spore chain morphology. Spores are extremely important
in the taxonomy of Actinobacteria (32). The initial steps of sporu-
lation in several oligosporicActinobacteria can be regarded as bud-
ding processes, because they satisfy themain criteria used to define
budding in other bacteria (Fig. 2). Spores may be formed on the
substrate and/or the aerial mycelium as single cells or in chains of
different lengths. In other cases, sporesmay be harbored in special
vesicles (sporangia) and endowed with flagella.
Thus, in the genera Micromonospora, Micropolyspora, and
Thermoactinomycètes, spore formation occurs directly on the sub-
stratemycelium (33), whereas in Streptomyces the spores grow out
from the aerial mycelium. The Actinoplanes and Actinosynnema
groups are characterized bymotile spores, whileThermoactinomy-
ces has unique heat-resistant endospores (33). Some otherActino-
bacteria genera have sclerotia (Chainia), synnemas (Actinosyn-
nema), vesicles that contain spores (Frankia), or vesicles that are
devoid of spores (Intrasporangium). Other genera, such asActino-
planes, Ampulariella, Planomonospora, Planobispora, Dactylospo-
rangium, and Streptosporangium, are classified based on their spo-
rangial morphology. Figure 2 illustrates the different types of
spores that can be found in actinomycetal genera. Finally, the
morphology of the spores themselves can also be used to charac-
terize species: they may have smooth, warty, spiny, hairy, or ru-
gose surfaces (34).
(iii) Spore chain length. The number of spores per spore chain
varies widely from genus to genus. The genera Micromonospora,
Salinispora, Thermomonospora, Saccharomonospora, and Promi-
cromonospora produce isolated spores, while Microbispora pro-
duces spores in longitudinal pairs. Members of the genera Actino-
madura, Saccharopolyspora, Sporicthya, and some Nocardia spp.
have short spore chains, while members of the genera Streptomy-
ces,Nocardioides,Kitasatospora, Streptoverticillium, and someNo-
cardia spp. produce very long chains of up to 100 spores. In con-
trast, Frankia species produce sporangia, which are essentially
bags of spores. Streptomycetes’ spore chains can be classified as
being straight to flexuous (Rectus-Flexibilis), open loops (Reli-
naculam-Apertum), open or closed spirals (spira), or verticillate
(35).
(iv) Melanoid pigments. Melanins are polymers with diverse
molecular structures that typically appear black or brown and are
formed by the oxidative polymerization of phenolic and indolic
compounds. They are produced by a broad range of organisms,
ranging from bacteria to humans. Actinobacteria have long been
known to produce pigments, which may be red, yellow, orange,
pink, brownish, distinct brown, greenish brown, blue, or black,
depending on the strain, the medium used, and the age of the
culture (4).
Generally referred to asmelanins, ormelanoid pigments, these
brown-black metabolic polymers are important not only because
of their usefulness in taxonomic studies but also because of their
similarity to soil humic substances (36, 37). Melanins are not es-
sential for the organisms’ growth and development, but they play
a crucial role in improving their survival and competitiveness.
FIG 2 Schematic drawings of the different types of spore chains produced by
actinomycetes.
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Chemotaxonomic classification. Chemotaxonomy is the use
of the distribution of chemical components to group organisms
according to the similarities of their cellular chemistries (38, 39).
The most commonly used chemical components in such system-
atics are cell wall amino acids, lipids, proteins, menaquinones,
muramic acid types, sugars, and the base composition of DNA
(40, 41). Chemotaxonomic classification and identification can
also be performed on the basis of information derived from
whole-organism chemical fingerprinting techniques. Below, we
discuss chemotaxonomicmarkers that have been reported to be of
particular value for the classification and identification of actino-
mycetes (1).
Analysis of the cell wall composition of Actinobacteria is taxo-
nomically valuable because it differs between suborders (42). In
particular, information on the chemical architecture of the pepti-
doglycan in the cell wall is valuable for classifying actinomycetes
because it facilitates discrimination between groups of Actinobac-
teria above the genus level.Multiple discriminatory characteristics
relating to the structure and composition of their peptidoglycans
have been identified (43), including the identity of the amino acid
in position 3 of the tetrapeptide side chain, the presence or ab-
sence of glycine in interpeptide bridges, and the peptidoglycan’s
sugar content (43). The presence or absence of specific optical
isomers of the chiral nonproteinogenic amino acid 2,6-diamin-
opimelic acid (DAP) is another chemotaxonomically important
characteristic of the cell walls of Gram-positive bacteria: the
peptidoglycan of Actinobacteria may contain either LL- or DL-
(meso)-DAP, depending on the genus. By considering DAP
isomerism and the presence/absence of other amino acids and
(amino)sugars, Lechevalier and Lechevalier (44) identified
nine distinct actinobacterial cell wall chemotypes (Table 1).
However, it is important to realize that while DAP analysis and
other chemotaxonomic methods are extremely important in
the taxonomy of Actinobacteria, diverse groups share the same
DAP profile. For example, the genera Streptomyces, Streptoverti-
cillium, Arachnia, and Nocardioides share the same chemotype
(chemotype I), even though their different morphologies indi-
cate that they belong to different families. Therefore, when
assessing the phenotypic diversity of Actinobacteria, DAP pro-
filing should be used in combination with other phenotypic or
genotypic criteria (45). To this end, a system for classifying
Actinobacteria based on both morphological and chemical char-
acteristics has been proposed (4).
Cellular fatty acid patterns are also very useful chemotaxo-
nomic indicators for the identification of specific Actinobacteria
genera (46). Bacterial fatty acids range in chain length from two
(C2) to over 90 (C90) carbon atoms, but only those in the range of
C10 to C24 are of particular taxonomic value (47). Three major
types of fatty acid profiles have been identified in Actinobacteria
(46).
Several types of isoprenoid quinones have been characterized
in bacteria (48), of which menaquinones are most commonly
found in actinomycete cell envelopes (46–49). Menaquinone
analysis has provided valuable information for the classification of
Actinomadura, Microtetraspora, and Streptomyces strains (46, 50–
52). In addition, cyclic menaquinones are characteristic of mem-
bers of the genus Nocardia (53, 54), while fully saturated cyclic
menaquinones have been reported for Pyrobaculum organotro-
phum (54).
Different types of phospholipids are discontinuously distrib-
uted in actinomycetes’ cytoplasmic membranes, providing useful
information for the classification and identification of actinomy-
cete genera (41, 55). Actinobacteria have been classified into five
phospholipid groups based on semiquantitative analyses of major
phospholipidmarkers found in whole-organism extracts (56–58).
This classification system was used in the identification of Aero-
microbium (59) and Dietzia (60). Importantly, it has been re-
ported that members of the same Actinobacteria genus have the
same phospholipid type.
Finally, sugar composition analysis is also important in che-
motaxonomy. At the suprageneric level, neutral sugars (the
major constituents of actinomycete cell envelopes) are useful
taxonomic markers (Table 2). On the basis of the discontinu-
ous distribution of major diagnostic sugars, Actinomycetes can
be divided into five groups. Group A comprises those species
whose cell walls contain arabinose and galactose; group B cell
walls contain madurose (3-O-methyl-D-galactose); group C
consists of those with no diagnostic sugars; group D cell walls
contain arabinose and xylose; group E cell walls contain galac-
tose and rhamnose (22, 61). In addition, the presence of 3=-O-
methyl-rhamnose in Catellatospora (62) and of tyvelose in Agro-
TABLE 1 Different types of cell wall components in Actinomycetesa
Cell wall type Major parietal constituent(s) Genera
I LL-DAP, glycine, no sugar Arachnia, Nocardioides, Pimelobacter, Streptomyces
II meso-DAP, glycine, arabinose, xylose Actinomyces, Actinoplanes, Ampulariella, Catellatosporia, Dactylosporangium, Glycomyces,
Micromonospora, Pilimelia
III meso-DAP, madurose (3-O-methyl-D-galactose) Actinocorallia, Actinomadura, Dermatophylus, Frankia, Geodermatophilus, Kitasatospora,
Maduromycetes, Microbispora, Microtetraspora, Nonomuraea, Planobispora,
Planomonospora, Planotetraspora, some Frankia spp., Spirillosporia,
Streptosporangium, Thermoactinomyces, Thermomonospora
IV meso-DAP, arabinose, galactose Micropolyspora, Nocardioforms
V Deprived of DAP; possesses lysine and ornithine Actinomyces
VI Deprived of DAP; variable presence of aspartic
acid, galactose
Arcanobacterium, Actinomyces, Microbacterium, Oerskovia, Promicromonospora
VII Deprived of DAP; diaminobutyric acid, glycine,
with lysine variable
Agromyces, Clavibacter
VIII Deprived of DAP; ornithine Aureobacterium, Curtobacterium, Cellulomonas
a Information summarized in this table was obtained from references 14, 45, 61, and 602.
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TABLE 2 Taxonomic markers used as characteristics to differentiate the genera of Actinomycetes
Amino acid present Sugar(s) Morphological characteristics Genus
No diaminopimelic
acid
Xylose, madurose Only substrate mycelium, breaks into motile elements Oerskovia
Sterile aerial mycelium, breaks into nonmotile elements Promicromonospora
Sporangia with motile spores Actinoplanes
Short chains of conidia on aerial mycelium Actinomadura
L-Diaminopimelic
acid
Xylose, madurose Both aerial and substrate mycelia that break up into rods and coccoid
elements
Nocardioides
Only substrate mycelium, bearing terminal or subterminal vesicles Intrasporangium
Aerial mycelium with long chains of spores Streptomyces, Kitasatospora
Sclerotia Streptomyces
Very short chains of large conidia on the vegetative and aerial mycelia Streptomyces
Whorls of small chains of spores Streptoverticillium
No aerial mycelium, sporangia on the vegetative mycelium Kineosporia
meso-Diaminopimelic
acid
Xylose, arabinose Conidia isolated on the vegetative mycelium Micromonospora
No sporangia, short chains of conidia Cattellatospora
Chains of conidia on the aerial mycelium Glycomyces
Dactyloid oligosporic sporangia, motile spores Dactylosporangium
Sporangia with spherical and motile spores formed on the surfaced of colonies Actinoplanes
Sporangia with rod-shaped spores, motility via polar flagella Ampullariella
Sporangia with lateral flagellated spores Pilimelia
Multilocular sporangia, spores are nonmotile Frankia
Madurose Short chains of conidia on the aerial mycelium Actinomadura
Chains of conidia with spores Microbispora
Chains of conidia with 2 to 6 spores Microtetraspora
Sporangia with 2 motile spores Planobispora
Sporangia with 1 motile spore Planomonospora
Mycelium with spherical sporangia containing many rod-shaped, motile
spores
Spirillospora
Fructose Multilocular sporangia Frankia
Sporangia with motile spores Actinoplanes
Rhamnose, galactose Both substrate and aerial mycelia that break into nonmotile elements Saccharothrix
Rhamnose, galactose,
mannose
Same as Streptomyces Streptoalloteichus
Galactose Same as Streptomyces Kitasatospora
Arabinose, galactose Presence of nocardiomycolic acid (NMA) in whole cells; both substrate and
aerial mycelia fragment into rods and coccoid elements
Nocardia
Presence of NMA; rods and extensively branched substrate mycelium that
fragments into irregular rods and cocci
Rhodococcus
Presence of NMA; straight to slightly curved rods occur singly, in pairs, or in
masses; cells are nonmotile, non-spore forming, and do not produce aerial
hyphae
Tsukamurella
Presence of NMA; paired spores borne in longitudinal pairs on vegetative
hyphae; aerial mycelium is sparse
Actinobispora
No NMA, spores are long, cylindrical on aerial mycelium, formed by budding Pseudonocardia
No NMA; long chains of conidia on aerial mycelium Saccharomonospora
No NMA; aerial mycelium bearing long chains of conidia; halophilic Actinopolyspora
No NMA; substrate mycelium tends to break into nonmotile elements; aerial
hyphae may form and may also segment
Amycolata, Amycolatopsis
No NMA; aerial mycelium bearing curled hyphae embedded in amorphous
matrix
Kibdelosporangium
No NMA; both aerial and substrate mycelia bearing long chains of motile
spores
Aktinokineospora
No NMA; aerial mycelium tends to fragment into rods and cocci, short chains
of spores
Pseudoamycolata
Spores formed are not heat resistant Thermomonospora
Long chains of spores on aerial mycelium Nocardiopsis
Columnar hyphal structures called synnemata bearing chains of conidia
capable of forming flagella
Actinosynnema
Multilocular sporangia containing motile spores Geodermatophilus
Barka et al.
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myces (63) has been valuable for the classification of some
actinomycete taxa.
Molecular Classiﬁcation
More recently, the morphological and chemical classification of
actinomycetes have been challenged by molecular taxonomic
data, much of which were obtained thanks to the rapid advance-
ment of genome sequencing. Notably, some organisms that were
inappropriately placed in certain taxonomic groups have recently
been reclassified on the basis of molecular analyses (20). A recent
example is the final definition of Kitasatospora as a separate genus
within the Streptomycetaceae (17); genome sequencing resolved a
long-running debate about this group’s relationship with the ge-
nus Streptomyces and conclusively demonstrated that it is in fact a
separate genus (15, 16, 64, 65).
At present, a new species cannot be claimed without genetic
analysis based on sequencing the 16S rRNA gene and DNA-DNA
hybridization, and even genome sequencing is becoming routine.
Molecular and chemical composition criteria have been used to
group the order Actinomycetales into 14 suborders: Actinomy-
cineae, Actinopolysporineae, Catenulisporineae, Corynebacterineae,
Frankineae, Glycomycineae, Jiangellineae, Kineosporineae, Micro-
coccineae,Micromonosporineae,Propionibacterineae,Pseudonocar-
dineae, Streptomycineae, and Streptosporangineae (66). Moreover,
sequencing of 16S rRNA genes has led to the recognition of 39
families and 130 genera (Fig. 3). All groups previously assigned to
the taxonomic rank of “order” were recovered as being strictly
monophyletic based on thesemolecular and chemical criteria, but
some paraphyletic groups were foundwithin the rank “suborder.”
This might be because the classification was mainly based on 16S
rRNA gene trees, which were generated without bootstrap sup-
port and may thus include misleading results. The features of
some of these genera are summarized below.
The genus Tropheryma. The most-studied member of the ge-
nus Tropheryma is T. whipplei, the causative agent of Whipple’s
disease, which is characterized by intestinalmalabsorption leading
to cachexia and death. T. whipplei isolates are typically found in
human intracellular niches, such as inside intestinal macrophages
and circulating monocytes (67, 68). It has a condensed genome of
only 925,938 bp, with a GC content of only 46% (69, 70),
whereas other actinomycete genomes have much larger genomes
(up to 10 MBp) and higher GC contents. T. whipplei has a tro-
pism for myeloid cells, particularly macrophages, although it can
be found in various cell types. Further, genome sequencing re-
vealed a lack of key biosynthetic pathways and a lower capacity for
energy metabolism. Its small genome and lack of metabolic capa-
bilities suggest that T. whipplei has a host-restricted lifestyle (69).
Recent findings have shown that T. whipplei survives phagocyte
killing and replicates in macrophages by interfering with innate
immune activation (71).
The genus Propionibacterium. The genus Propionibacterium
includes various species belonging to the human cutaneous pro-
pionibacteria, including P. acnes, P. avidum, P. granulosum, P.
innocuum, and P. propionibacterium. Propionibacterium acnes is a
non-spore-forming, anaerobic, pleomorphic rod whose end
products of fermentation include propionic acid. The bacterium
is omnipresent on human skin, predominantly within sebaceous
follicles, where it is generally a harmless commensal. Nonetheless,
P. acnes may be an opportunistic pathogen (72). Indeed, the bac-
terium has been isolated from sites of infection and inflammation
in patients suffering from acne and other diverse conditions, in-
cluding corneal ulcers, synovitis, hyperostosis, endocarditis, pul-
monary angitis, and endophthalmitis (73, 74). Recently, Campi-
sano et al. (75) reported a unique example of horizontal
interkingdom transfer of P. acnes to the domesticated grapevine,
Vitis vinifera L.
The genus Micromonospora. Micromonospora species are
widely distributed in nature, living in different environments.
They have long been known as a significant source of secondary
metabolites for medicine, and it was recently demonstrated that
Micromonospora species may also influence plant growth and de-
velopment (76); Micromonospora strains have been identified as
natural endophytes of legume nodules, although the precise na-
ture and mechanism of their effects on plant development and
productivity are currently unclear. While the genus exhibits con-
siderable physiological and biochemical diversity, Micromono-
spora constitutes a well-defined group in terms of morphology,
phylogeny, and chemotaxonomy. Its colonies can be a variety of
colors, including white, orange, rose, or brown. However, species
of the genus Micromonospora are not always easy to differentiate
on the basis of morphology alone. Consequently, phylogenies and
species identifications are now more commonly derived by ana-
lyzing the sequence of the 16S rRNA gene or gyrB (the gene en-
codingDNA topoisomerase). The genusMicromonospora consists
primarily of soil actinobacteria, which account for 32 of its species,
according to the latest version of Bergey’s manual (77), although
50 soil actinobacteria in this genus have been validly described as
of the time of writing. Most of these species were isolated from
alkaline or neutral soils and to a lesser extent from aquatic envi-
ronments. The spore population ofM. echinospora is known to be
heterogeneous with respect to its heat response characteristics,
suggesting that routine heat activation could be utilized to elimi-
nate the natural variability that exists within populations of this
species and its relatives (78). Further, analysis of the genome ofM.
lupini Lupac 08 revealed a diverse array of genes that may help the
bacterium to survive in the soil or in plant tissues. However, de-
spite having many genes that encode putative plant material-de-
grading enzymes, this bacterium is not regarded as a plant patho-
gen (79). In addition, genome comparisons showed thatM. lupini
Lupac 08 is metabolically closely related to Frankia sp. strains
ACN14a, CcI3, and EAN1pec. These results suggest that the Mi-
cromonospora genus has undergone a previously unidentified pro-
cess of adaptation from a purely terrestrial to a facultative endo-
phytic lifestyle.
The genus has also been reported to produce a large number of
antibiotics (80) and is second only to Streptomyces in this respect,
synthesizing up to 500 differentmolecules with various properties
(77). Micromonospora species can produce hydrolytic enzymes,
which allows them to play an active role in the degradation of
organic matter in their natural habitats. Marine Micromonospora
species have recently been reviewed with respect to their broad
distribution and their potential use as probiotics (76, 81). Like
other endophytic actinobacteria, Micromonospora can suppress a
number of pathogens both in vitro and in planta by activating key
genes in the systemic acquired resistance (SAR) or jasmonate/
ethylene (JA/ET) pathways (76). Unfortunately, there have been
few genomic studies on Micromonospora species, and there is a
lack of tools for their genetic analysis despite their acknowledged
capacity for secondary metabolite production (76).
The genus Salinispora. Salinispora belongs to the Micromono-
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FIG 3 A genome-based phylogenetic tree based on 97 genome sequences of the phylum Actinobacteria. Type strain genome projects were selected as previously
described (676), provided that they yielded at most 25 contigs. Phylogenetic reconstruction, including the assessment of branch support, was done using amino
acid sequences according to themethods described byMeier-Kolthoff et al. (677, 678). The tree was visualized by using ITOL (679). Branch support values below
60% are not shown, but the tree generally reveals high support throughout.
Barka et al.
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sporaceae and is the first Actinobacteria genus known to require
seawater for growth (82). The genus is widely distributed in trop-
ical and subtropical marine sediments (83) and includes three
distinct but closely related clades corresponding to the species S.
arenicola, S. pacifica, and S. tropica. Like their terrestrial actinomy-
cete counterparts, Salinispora spp. produce numerous secondary
metabolites with diverse potential pharmaceutical applications.
For instance, salinosporamide A, isolated from S. tropica, is cur-
rently in phase 1 clinical trials in patients with multiple myeloma,
lymphomas, leukemia, and solid tumors (84).
Although the three currently known species of Salinispora
cooccur at six widely separated and distinct locations (82), only
strains of S. tropica isolated from the Caribbean produce the po-
tent anticancer compound salinosporamide A (85). In addition to
its production of various secondary metabolites, this genus has
attracted major interest for the novel phenomenon of species-
specific secondary metabolite production (86, 87). Although it is
clear that many of the genes for secondary metabolite production
in the Salinispora genomewere acquired via horizontal gene trans-
fer, the ecological and evolutionary significance of these mecha-
nisms remain unclear (86).
The genus Mycobacterium. The relatively simple morphology
of mycobacteria partly explains why it is sometimes overlooked
when considering criteria for classifying actinomycetes (88, 89).
With the genera Corynebacterium and Nocardia, Mycobacterium
forms a monophyletic taxon within the Actinobacteria, the so-
called CMN group (90). This group shares an unusual waxy cell
envelope that contains mycolic acids, meaning these bacteria are
unusual in being acid fast and alcohol fast. The mycobacterial cell
wall contains various polysaccharide polymers, including arabi-
nogalactan, lipomannan, lipoarabinomannan, and phosphatidyl-
inositol mannosides (91, 92). Representatives of the genus Myco-
bacterium have been the subjects of three major 16S rRNA
sequencing studies (93–95). Mycobacteria are generally free-liv-
ing saprophytes (96), and they are the causative agents of a broad
spectrumof humandiseases.Mycobacterial diseases are very often
associated with immunocompromised patients, especially those
with AIDS. In addition,M. bovis andM. tuberculosis, isolated ini-
tially from infected animals, are most likely obligate parasites of
humans (97). Both species can survive within macrophages and
cause pulmonary disease, although organs other than lungs may
be affected.M. leprae, which causes leprosy, lives in Schwann cells
and macrophages; infection with this species results in a chronic
granulomatous disease of the skin and peripheral nerves (98). In-
terestingly, the pathogenic M. ulcerans, which is the third most
common causative agent of mycobacterial disease, has also been
isolated as a soil inhabitant in symbiosis with roots of certain
plants living in tropical rain forests and similar environments (99,
100). Mycobacterium marinum was initially identified as a caus-
ative organism of tuberculosis in fish in 1926 (101) and was sub-
sequently shown to also cause skin disease in humans (102). M.
marinum is a nontuberculosis mycobacterium that is a causative
agent of human skin infections acquired through aquatic sources.
Most cases ofM.marinum infection are reported to have occurred
after exposure to contaminated aquarium water or contact with
fish and shellfish (103).
The genusNocardia.The genusNocardia is a ubiquitous group
of environmental bacteria that is most widely known as the caus-
ative agent of opportunistic infection in immunocompromised
hosts. It forms a distinct clade that is associated with the genus
Rhodococcus. Both theNocardia andRhodococcus genera belong to
the family Nocardiaceae, which is a suborder of the “aerobic acti-
nomycetes.” Nocardia species are ubiquitous soilborne aerobic
actinomycetes, with more than 80 different species identified, of
which at least 33 are pathogenic (104). Nocardia infections are
mainly induced through inhalation or percutaneous inoculation
from environmental sources (105), but nosocomial transmission
has also been reported. The pathogen can spread to the brain,
kidneys, joints, bones, soft tissues, and eyes, causing disseminated
nocardiosis in humans and animals (106). Although Nocardia
species are rare, they now account for 1 to 2% of all reported brain
abscesses. However, the mortality rate for brain abscesses associ-
ated with Nocardia infection is substantially higher (31%) than
that for brain abscesses in general (10%) (107).
Moreover, Nocardia species produce industrially important
bioactive molecules, such as antibiotics and enzymes (108, 109).
Within theNocardia clade, two sublines distinguishable by nucle-
otide differences in helix 37-1 are recognized; one consists of No-
cardia asteroides and allied taxa, while the second consists of No-
cardia otitidiscaviarum and related species.N. asteroides, the causal
agent for most clinical human nocardial infections, was reorga-
nized into multiple species on the basis of drug susceptibility pat-
terns:Nocardia abscessus, theNocardia brevicatena-Nocardia pau-
civorans complex, the Nocardia nova complex, the Nocardia
transvalensis complex,Nocardia farcinica, andN. asteroides (104).
Recently, Nocardia cyriacigeorgica was differentiated from N. as-
teroides (110).
In the last 2 decades, Nocardia infections have become re-
garded as an emerging disease among humans and domestic
animals worldwide because of improved methods for pathogen
isolation and molecular identification and a growing immuno-
compromised population (111).Nocardia species are recognized
as opportunistic pathogens (112) and are known to compromise
immune function. Moreover, they have been associated with or-
gan and bone marrow transplants (113), long-term steroid use,
connective tissue diseases, human immunodeficiency virus (HIV)
infections, chronic obstructive pulmonary disease, alcoholism,
cirrhosis, systemic vasculitis, ulcerative colitis, and renal failure
(114).
In companion animals, Nocardia infections are usually re-
ported as coinfections with immunosuppressive infectious dis-
eases such as distemper in dogs and leukemia and immunodefi-
ciency in cats (115).
The genus Corynebacterium. The genus Corynebacterium was
initially defined in 1896 to accommodate mainly pathogenic spe-
cies exhibiting morphological similarity to the diphtheroid bacil-
lus (116). Therefore, the genus comprised, for several decades, an
extremely diverse collection of morphologically similar Gram-
positive microorganisms, including nonpathogenic soil bacteria
(117). Following chemotaxonomic studies and 16S rRNA se-
quence analysis, there are currently almost 70 recognized Coryne-
bacterium species. Some well-known representatives include C.
glutamicum, which (like the thermostable C. efficiens) is widely
used in industry for the production of amino acids such as L-glu-
tamic acid and L-lysine for human and animal nutrition, respec-
tively (118). Several genome sequences of Corynebacterium spe-
cies have been reported, including those of C. ulcerans (119), C.
kutscheri (120), C. kroppenstedtii (121), and C. argentoratense
(122), providing important new insights into the genomic archi-
tecture of the genus. A prophage, CGP3, that integrates into the
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genomeofC. glutamicum and encodes an actin-like protein, AlpC,
was recently described (123). CGP3 appears to be inactive in terms
of cell lysis and virion production and is therefore referred to as a
cryptic prophage, which likely became trapped in the genome in
the course of evolution (123). This suggests that bacterial phages
use an actin-based transport system similar to that found in ver-
tebrate viruses, such as the herpesvirus. Among the known patho-
genic members of Corynebacterium are C. diphtheria, which is a
notorious strictly human-adapted species and the causative agent
of the acute, communicable disease diphtheria, which is charac-
terized by local growth of the bacterium in the pharynx along with
the formation of an inflammatory pseudomembrane (124). The
virulence factor in diphtheria is an exotoxin that targets host pro-
tein synthesis (125). Another important Corynebacterium patho-
gen is C. ulcerans, which is increasingly acknowledged as an
emerging pathogen in various countries; infections with this spe-
cies can mimic diphtheria because it harbors lysogenic--cory-
nephages that carry the the diphtheria toxin (DT) gene, which is
responsible for most of the systemic symptoms of diphtheria
(126). C. ulcerans also induces clinical symptoms in the lower
respiratory tract, including pneumonia (127) and pulmonary
granulomatous nodules (128). However, its pathogenicity does
not necessarily depend on the production of DT (129). A final
important pathogen in this genus is C. jeikeium, which was ini-
tially isolated from human blood cultures and is associated with
bacterial endocarditis contracted following cardiac surgery (130).
It was subsequently shown to be a natural inhabitant of human
skin and has been implicated in a variety of nosocomial infections
(131).
The genus Gordonia. Initially proposed by Tsukamura (132),
this genus has been isolated from the sputum of patients with
pulmonary disease and also from soil samples. There are currently
29 validly described species in this genus (1). Bacteria of this genus
are aerobic and catalase positive, forming rods and cocci. The
gordonae arewidely distributed and are common in soil, but some
strains have been linked with foams found in activated sludge at
sewage treatment plants. Three species originally assigned to Rho-
dococcus, namely, R. bronchialis (132), R. rubropertinctus (133),
and R. terrae (132), have more recently been reaffiliated to the
genus Gordona as Gordona bronchialis (132), Gordona rubroper-
tincta (133), and Gordona terrae (132). The original spelling Gor-
dona (sic) was corrected to Gordonia by Stackebrandt et al. (134).
The genus Rhodococcus. The genus Rhodococcus is a heteroge-
neous group of microorganisms whose members are more closely
related to those of the genus Nocardia than to those of the genus
Mycobacterium. Rhodococcus species include symbionts (Rhodo-
coccus rhodnii) and pathogens to animals (e.g., R. equi), plants
(Rhodococcus fascians), and humans (e.g., R. equi, R. rhodochrous,
and R. erythropolis) (135). Rhodococcus equi is the Rhodococcus
species that ismost likely to act as a pulmonary pathogen in young
horses and HIV-infected humans (136).
TheRhodococcus genus has had a long and confused taxonomic
pedigree (137, 138). However, many of the early uncertainties
have been resolved satisfactorily through the application of che-
motaxonomic and phylogenetic character analyses. In the last edi-
tion of Bergey’s Manual of Systematic Bacteriology, rhodococci
were assigned to two aggregate groups based primarily on chem-
ical and serological properties (21). Key diagnostic characteristics
for rhodococci are the presence of tuberculostearic acid, mycolic
acids with lengths of between 34 and 64 carbon atoms, and with
the major menaquinone type being dihydrogenated menaquino-
nes that possess eight isoprenoid units but which lack the cyclic
element that is the characteristic motif of the Nocardia genus
(135).
Rhodococci are aerobic, Gram-positive, catalase-positive, par-
tially acid-fast, nonmotile actinomycetes that can grow as rods but
also as extensively branched substrate hyphae. Some strains pro-
duce sparse, aerial hyphae that may be branched or form aerial
synnemata, which consist of unbranched filaments that coalesce
and project upwards (53). Rhodococci are very important organ-
isms with remarkably catabolic versatility, because they carry
genes encoding enzymes that can degrade an impressive array of
xenobiotic and organic compounds (139). In addition to their
bioremediation potential, they produce metabolites of industrial
potential, such as carotenoids, biosurfactants, and bioflocculation
agents (140). Some species, such as Rhodococcus rhodochrous, also
synthesize commercially valuable products, such as acrylamide
(135).
The nomenclature of Rhodococcus equi remains controversial.
In a commentary on the nomenclature of this equine pathogen,
Goodfellow et al. (141) noted that the taxon is regrettably left
without a valid name, because Rhodococcus itself is an illegitimate
name and, according to the nomenclature code, should not be
used. “Prescottella equi”was suggested as a newname for the taxon
that would provide nomenclatural stability; consequently, clini-
cians and scientists working on this taxon should adopt the name
“P. equi.”
The genus Leifsonia. Evtushenko et al. (142) introduced the
genus Leifsonia to accommodate Gram-positive, non-spore-
forming, irregular rod- or filament-shaped, motile, mesophilic,
catalase-positive bacteria containing DL-2,4-diaminobutyric acid
in their peptidoglycan layer. Currently, the genus harbors 12 spe-
cies and two subspecies, with Leifsonia aquatica as the type species.
Members of the genus Leifsonia have been isolated from different
ecological niches, including plants (L. poae and L. xyli), soil (L.
naganoensis and L. shinshuensis), distilled water (e.g., L. aquatica),
Himalayan glaciers, and Antarctic ponds (L. rubra and L. aurea)
(142–146).
Leifsonia xyli comprises two subspecies: L. xyli subsp. cynodon-
tis, a pathogen that causes stunting in Bermuda grass (Cynodon
dactylon), and L. xyli subsp. xyli (142). Information on the biology
and pathogenicity of L. xyli subsp. xyli is limited. Like the gamma-
proteobacterium Xylella fastidiosa, L. xyli subsp. xyli belongs to a
unique group of xylem-limited and fastidious bacterial pathogens
and is the causative agent of ratoon stunting disease, the main
sugarcane disease worldwide (147).
The genus Bifidobacterium. Bifidobacteria, first isolated by
Tissier (148), are the only family of bacteria in the order Bifido-
bacteriales. The Bifidobacteriaceae family contains the type genus
Bifidobacterium (149), and members of the family Bifidobacteri-
aceae have different shapes, including curved, short, and bifur-
cated Y shapes. They were initially classified as Bacillus bifidus
communis. The cells have no capsule and they are non-spore-
forming, nonmotile, and nonfilamentous bacteria. The genus en-
compasses bacteria with health-promoting or probiotic proper-
ties, such as antimicrobial activity against pathogens that is
mediated through the process of competitive exclusion (150), and
also bile salt hydrolase activity, immunemodulation, and the abil-
ity to adhere to mucus or the intestinal epithelium (151). For
commercial exploitation, bifidobacterial strains are typically se-
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lected for fast growth, antibacterial activity, good adhesion prop-
erties, and utilization of prebiotic substrates (151). Among the
many probiotic features that have been attributed to bifidobacte-
ria are (i) the induction of immunoglobulin production, (ii) im-
provement of a food’s nutritional value by assimilation of sub-
strates not metabolized by the host, (iii) anticarcinogenic activity,
and (iv) folic acid synthesis (152–154). Some bifidobacteria pro-
duce antimicrobials (155) and notably, also bacteriocins (156,
157).
ThegenusGardnerella.Classification for the genusGardnerella
is controversial: the genus has often been described as Gram vari-
able but has a Gram-positive wall type (158).Gardnerella vaginalis
is a facultative anaerobic bacterium and the only species of this
genus belonging to theBifidobacteriaceae family (159).G. vaginalis
is strongly associated with bacterial vaginosis, a disease character-
ized bymalodorous vaginal discharge, but it also occurs frequently
in the vaginal microbiota of healthy individuals (160). G. vagina-
lis-associated vaginosis is a risk factor for poor obstetric and gy-
necologic outcomes, as well as the acquisition of some sexually
transmitted diseases. In addition, clinical studies have demon-
strated a relationship between G. vaginalis and preterm delivery
(161). The issue of G. vaginalis commensalism is still ambiguous,
as the vaginal bacterial community is dynamic and tends to
change over themenstrual cycle, leading to a transient dominance
of G. vaginalis even in healthy women (162).
The genus Streptomyces. The various mycelial genera of Acti-
nobacteria harbor some of the most complex known bacteria
(163), such as Streptomyces, Thermobifida, and Frankia. Of the
three genera, Streptomyces has received particular attention for
three main reasons. First, streptomycetes are abundant and im-
portant in the soil, where they play major roles in the cycling of
carbon trapped in insoluble organic debris, particularly from
plants and fungi. This action is enabled by the production of di-
verse hydrolytic exoenzymes. Second, the genus exhibits a fairly
wide phylogenetic spread (164). Third, streptomycetes are among
Nature’s most competent chemists and produce a stunning mul-
titude and diversity of bioactive secondary metabolites; conse-
quently, they are of great interest in medicine and industry (165).
Streptomycetes are the only morphologically complex Actinobac-
teria whose development has been considered in detail. For more
details on this genus, which serves as a model system for bacterial
antibiotic production, see the section on “Physiology and Antibi-
otic Production of Streptomyces,” below.
The genus Frankia. Frankia is the only nitrogen-fixing actino-
bacterium and can be distinguished by its ability to enter into
symbiotic associations with diverse woody angiosperms known
collectively as actinorhizal plants. The most notable plant genera
in this group are Alnus,Casuarina, and Elaeaginus, and their sym-
biosis with Frankia enables them to grow well in nitrogen-poor
soils (166, 167). Like Streptomyces, the DNA of Frankia has a par-
ticularly high GC content of 72 to 73% (2). Frankia can form
three different cell types, growing as mycelia or as multilocular
sporangia. Under nitrogen-limited and aerobic conditions,
Frankia develops so-called vesicles at the tips of hyphae or at the
ends of short side hyphae (168). For a long time, Frankia spp. were
believed to be the only bacteriawithin theActinobacteria able to fix
atmospheric nitrogen. However, Gtari et al. (169) recently re-
viewed the sparse physiological and biochemical studies con-
ducted onActinobacteria over the last 50 years and concluded that
nitrogen fixation within this group is unlikely to be restricted to
frankiae.
The genus Thermobifida. The genus Thermobifida, established
by Zhang et al. (170), was originally assigned to the highly heter-
ogeneous genus Thermomonospora. A phylogenetic analysis based
on 16S rRNA sequences prompted the reclassification of Thermo-
bifida alba and Thermobifida fusca, which were previously classi-
fied as Thermomonospora species (33, 137). Later, Thermobifida
cellulolytica was added to this genus (171). More recently, Ther-
mobifida halotolerans sp. nov. was proposed as representative of a
novel species of Thermobifida (172). Members of the genus Ther-
mobifida are Gram-positive, non-acid-fast, chemo-organotrophic
aerobic organisms that form an extensively branched substrate
mycelium. Thermobifida species are moderately thermophilic,
growing optimally at 55°C, and act asmajor degraders of plant cell
walls in heated organic materials, such as compost heaps, rotting
hay, manure piles, or mushroom growth medium.
PHYSIOLOGY AND ANTIBIOTIC PRODUCTION OF
STREPTOMYCES
The Streptomyces Life Cycle
Streptomycetes play key roles in soil ecology because of their abil-
ity to scavenge nutrients and, in particular, to hydrolyze a wide
range of polysaccharides (cellulose, chitin, xylan, and agar) and
other natural macromolecules (173). The life cycle of the multi-
cellular mycelial Streptomyces starts with the germination of a
spore that grows out to form vegetative hyphae, after which a
process of hyphal growth and branching results in an intricately
branched vegetative mycelium (174). A prominent feature of the
vegetative hyphae of Streptomyces is that they grow by tip exten-
sion (28). This in contrast to unicellular bacteria, like Bacillus
subtilis and Escherichia coli, where cell elongation is achieved by
incorporation of new cell wall material in the lateral wall (175).
Exponential growth of the vegetative hyphae is achieved by a com-
bination of tip growth and branching. The fact that cell division
during vegetative growth does not lead to cell fission but rather to
cross-walls that separate the hyphae into connected compart-
ments (176) makes streptomycetes a rare example of a multicel-
lular bacterium,with each compartment containingmultiple cop-
ies of the chromosome (177, 178). The spacing of the vegetative
cross-walls varies significantly, both between different Streptomy-
ces species and within individual species between different growth
conditions and mycelial ages.
Under adverse conditions, such as nutrient depletion, the veg-
etative mycelium differentiates to form erected sporogenic struc-
tures called aerial hyphae. This is also the moment in the life cycle
when most antibiotics are produced (179, 180). Streptomyces and
other filamentous microorganisms are sessile; when nutrient de-
pletion occurs, the vegetative or substrate mycelium is autolyti-
cally degraded by a programmed cell death (PCD)-like mecha-
nism to acquire the building blocks needed to erect a secondmass
of (aerial) mycelium (181–183). PCD results in the accumulation
of amino acids, aminosugars, nucleotides, and lipids around the
lysing substrate mycelium (184–186), which inevitably attract
motile competing microbes in the habitat; it is logical to assume
that antibiotics are produced at this time to protect the pool of
nutrients. One well-studied system revolves around the PCD-re-
sponsive nutrient sensory regulator DasR, which controls early
development and antibiotic production and responds to the accu-
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mulation of cell wall-derived N-acetylglucosamine (186, 187).
The role of DasR as a regulator of antibiotic production is dis-
cussed in more detail in the section on controlling antibiotic pro-
duction. A cascade of extracellular proteases and protease inhibi-
tors also plays a well-established role in PCD and development in
streptomycetes, as reviewed elsewhere (173, 188).
Two rounds of PCD occur during the Streptomyces life cycle
(189). After spore germination, a compartmentalized mycelium
grows out and then undergoes a first round of PCD that affects the
material formed during early vegetative growth. This is then fol-
lowed by a second round of PCD that is initiated during the onset
of development (189). At this stage, the vegetative or substrate
hyphae are lysed so as to provide nutrients for the next round of
biomass formation, i.e., the growth of the aerial mycelium. The
aerial hyphae give the colonies their characteristic fluffy appear-
ance and eventually differentiate to form chains of unigenomic
spores (23). Genes that are required for the formation of aerial
hyphae are referred to as bld genes, in reference to the bald (“hair-
less”) phenotype ofmutants lacking the fluffy aerial hyphae (190),
while mutants whose development is blocked at a stage prior to
sporulation are called whi (white), due to their failure to produce
the gray spore pigment (174, 191).
Genes that are required for aerial growth or for sporulation
were originally identified by screening for mutants after random
mutagenesis by using UV irradiation or treatment with chemical
mutagens, or by transposon-mediated mutagenesis, resulting in a
collection of bld andwhimutants that were subsequently classified
on the basis of their morphology (174, 190–195). Several new
classes of developmental genes have been identified on the basis of
physiological criteria, such as the acceleration of aerial mycelium
formation in S. lividans (ram genes, for rapid aerial mycelium
[196]), complementation of mutants of S. griseus with disturbed
sporulation (ssgA-like genes, for sporulation of Streptomyces gri-
seus [197]), or disruptions in sugar metabolism (186, 198, 199).
Most bld and whi genes that have been identified to date have a
(predicted) regulatory function at the transcriptional or transla-
tional level, with many encoding predicted transcription factors.
Some of the best-studied examples are bldD, a highly pleiotropic
transcription factor that controls hundreds of development-re-
lated genes (200–202), the RNA polymerase  factors bldN (203)
and whiG (204, 205), which control early events during sporula-
tion (although bldN is also strongly transcribed during aerial
growth), and whiH, which controls the onset of sporulation-spe-
cific cell division (206, 207). There is also extensive control at the
translational level. A wonderful example is bldA, which specifies a
tRNA molecule responsible for the translation of the rare leucine
codonUUA(208, 209).Deletion of bldAhas a pleiotropic effect on
gene expression in streptomycetes (210, 211). A major target of
bldA-mediated translational control is bldH (adpA), which en-
codes an important global regulator of development and antibi-
otic production (212–215). Transcription of adpA is activated in
response to the -butyrolactone A-factor in S. griseus and to the
related molecule SCB1 in S. coelicolor (216–220). An interesting
feedback loop exists whereby the translation of the adpA mRNA
depends on BldA (221, 222), while AdpA in turn controls bldA
transcription (223).
Recently, it was elegantly shown by the group of Mark Buttner
that the activity of BldD, which represses many developmental
genes during vegetative growth, is controlled posttranslationally
by the signalingmolecule cyclic-di-GMP (CDG) (224). Binding of
tetrameric CDG to BldD brings together the DNA binding do-
mains of the BldD dimer, thus enabling the protein to bind to its
target sites (224). An example ofmetabolic control is presented by
the pleiotropic nutrient sensory regulator DasR, which is essential
for development and pleiotropically represses antibiotic produc-
tion (see below). DNA binding by DasR is controlled by the bind-
ing of GlcNAc-related metabolites as ligands (186, 225). An over-
view of key developmental events and regulatory networks in
streptomycetes is presented in Fig. 4. An extensive overview of the
very complex and intriguing regulatory networks that control
the onset of sporulation is beyond the scope of this review;we refer
the reader to the excellent previously published reviews of this
field for further information (23, 173, 188, 226, 227).
Environmental Control of Aerial Hypha Formation
In addition to being defective in aerial hypha formation, early
developmental (bld) mutants also exhibit disrupted antibiotic
production. This underlines the connection between develop-
ment and secondary metabolism (see below). Most bld mutants
fail to produce antibiotics, although some, in particular bldF, are
antibiotic overproducers. By definition, all of the nonessential
genes that are required for aerial hypha formation are bld genes.
Extracellular complementation experiments where bld mutants
were grown in close proximity to one another without physical
contact suggested the existence of a hierarchical relationship be-
tween at least some of the bld genes (228–231). Aerial hypha for-
mation could be restored from one bldmutant to another, which
is consistent with the idea of a signaling cascade that generates a
signal that ultimately leads to the onset of development. However,
these experiments were almost exclusively performed on a single
reference medium, namely, nutrient-rich R2YE agar plates with
glucose, and many bld mutants have a conditional bald pheno-
type—in other words, they are able to produce at least some aerial
hyphae and spores on minimal media with nonrepressive carbon
sources, such as mannitol (192, 198, 227). A logical assumption is
that this is the result of carbon catabolite repression (CCR),
whereby favorable carbon sources such as glucose signal the pres-
ence of abundant food, thus favoring growth over development
and antibiotic production (232, 233).
In streptomycetes, CCR largely depends on the glycolytic en-
zyme glucose kinase, and deletion of the glkA gene encoding glu-
cose kinase therefore abolishes CCR (232, 234, 235). Suggestively,
deleting glkA in bldA mutants of S. coelicolor restores their ability
to sporulate on glucose-containing media (236). Conversely, mu-
tants that lack the bldB gene (which encodes a small 99-amino-
acid [aa] protein) are defective in CCR, although the mode of
action of BldB is as yet unclear (192, 237). It should be noted that
Glk-independent pathways of CCR that affect development and
antibiotic production also exist, adding further complexity to the
picture (238). Other bld genes relevant to sugar metabolism are
ptsH, ptsI, and crr, which encode the global components HPr,
enzyme I (EI), and enzyme IIA (EIIACrr), respectively, of the
phospohoenolpyruvate (PEP)-dependent phosphotransferase
system (PTS), which transports sugars such as N-acetylgluco-
samine and fructose in S. coelicolor (239, 240). Other examples are
dasABC, which encodes a chitobiose sugar transporter (199, 241),
and the pleiotropic sugar regulators atrA (242) and dasR (186,
187). Perhaps surprisingly, the nonsporulating phenotype of the
das and pts transportmutants is independent of the carbon source
and thus probably also of the transport activity (186, 199, 241).
Barka et al.
12 mmbr.asm.org March 2016 Volume 80 Number 1Microbiology and Molecular Biology Reviews
 o
n
 February 8, 2017 by W
ALAEUS LIBRARY/BIN 299
http://m
m
br.asm
.org/
D
ow
nloaded from
 
These examples highlight the important and complex connections
between carbon utilization and development in streptomycetes.
Metals also play a key role in the onset of development. Strep-
tomyces lividans requires a large amount of copper for proper aer-
ial growth (243). This defect can be rescued by enhanced expres-
sion of the ram cluster (196), which ultimately leads to the
production of the surfactant SapB (see the next section). Recently,
Sébastien Rigali and colleagues showed that development can be
restored to bldJ and bldK mutants by supplementing R2YE agar
with iron (244). The bldK gene cluster encodes an oligopeptide
transporter (228, 245), while the function of bldJ is unknown
(228). Interestingly, mass spectrometric analysis revealed that all
of the bldmutants that were tested showed either severely reduced
(for bldA, bldJ, and ptsHmutants) or enhanced (for bldF, bldK, crr,
and ptsI mutants) production of the iron-binding siderophore
desferrioxamine (244). The same paper also mentioned unpub-
lished data suggesting that deregulated desferrioxamine produc-
tion occurs in bldB, bldC, bldD, dasA, and adpA mutants when
grownonR2YE agar plates andmay thus be amore general feature
of many bld mutants (244). Further complications arise from the
fact that both bldJ mutants and mutants lacking the citA gene for
citrate synthase (which also fail to develop on R2YE under “stan-
dard” conditions), do successfully develop on R2YEwhen theme-
dium is strongly buffered (246). Besides shedding more light on
the nature of bld mutations, these experiments also show that
environmental factors, such as metal availability, pH, and carbon
and nitrogen sources, have profound effects on the onset of devel-
opment, and so the composition of the medium should be con-
sidered very carefully when planning experiments to study devel-
opment in streptomycetes.
Facilitating Aerial Growth: the Roles of Chaplins, Rodlins,
and SapB
Aerial hyphae differ substantially from vegetative hyphae. One
major difference is that aerial hyphae ofwild-type cells typically do
not branch extensively, are nearly twice as wide as vegetative hy-
phae, and undergo rapid growth. The aerial hyphae are also sur-
rounded by a sheath that later becomes part of the spore coat
(247–251). This sheath is hydrophobic on the air-facing side, al-
lowing the aerial hyphae to break through the moist soil-air sur-
face with the assistance of the turgor pressure generated by the
hyphae (252, 253), similarly to what has been proposed for fungi
(254). Chaplins are potent surfactants, reducing the surface ten-
sion from 72 to 24 mJ m2 (247, 255). An important function of
the sheath may also be to create a channel along the outer hyphal
wall that can facilitate nutrient transport, as proposed by Keith
FIG 4 Major events during development of Streptomyces. Nutrient stress is a major trigger of development, leading to the accumulation of ppGpp, resulting in
cessation of early growth and repression of the nutrient sensory DasR protein by cell wall-derived metabolites following PCD of the substrate mycelium. Bld
proteins and environmental signals control the procession toward aerial growth and antibiotic production. The developmental master regulator BldD (when
bound to tetrameric cyclic-di-GMP) represses the transcription of genes for many key developmental regulatory proteins, including WhiB, WhiG, SsgA, and
SsgB, as well as FtsZ. Chaplins and SapB provide a supportive hydrophobic layer to allow aerial hyphae to become erect and break through themoist soil surface.
White proteins control aerial growth, wherebyWhiAB and SsgB likely play a role in growth cessation. Eventually, FtsZ accumulates and localizes to septum sites
in an SsgAB-dependent manner. Ladders of FtsZ are formed, which subsequently delimit the spore compartments. Chromosome condensation and segregation
are followed by septum closure and sporematuration. The onset of antibiotic production typically correlates temporally to the transition from vegetative to aerial
growth. Solid black arrows represent major transitions in development. Dark dotted lines indicate transcriptional control (arrows for activation, ovals for
repression).
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Chater (173, 256). This argument suggests that nutrients and
other metabolites might diffuse from the vegetative hyphae in the
basal part of the colony up to the growing tips of the aerial hyphae
(173, 256), which would be an attractive alternative to transport
through hyphae and could potentially resolve the longstanding
debate about how nutrients are transported efficiently across long
distances over the cross-walls (188).
The sheath consists of a number of hydrophobic proteins, in
particular chaplins and rodlins (230, 247, 249, 257–260). To-
gether, these proteins form the so-called rodlet layer, which
decorates the spores with a seemingly random pattern of small
lines running in all directions; high-resolution electron mi-
croscopy shows that these lines consist of small protein assem-
blies (Fig. 5). Typical rodlet layer formation depends on the
rodlin proteins RdlA and RdlB; deletion of the rdl genes instead
results in decoration with fine lines consisting of the chaplins
(248). S. coelicolor contains eight chaplins, three large ones
(ChpABC) with two chaplin domains and a sortase domain and
five smaller chaplins (ChpDEFGH) bearing a single chaplin
domain (247, 249). The chaplins assemble on the hyphal sur-
face into an amphipathic protein layer that consists of amyloid-
like fibrils. Of the chaplins, the vegetatively expressed ChpC,
ChpE, and ChpH proteins are sufficient for sporulation (261).
ChpE and ChpH are secreted into the surrounding medium to
reduce the surface tension so as to enable the hyphae to grow
into the air (247, 255).
Closer analysis of the ChpH protein showed that it has two
amyloidogenic domains at its N and C termini, which are both
required for aerial hypha formation, while only the C-terminal
domain is required for assembly of the rodlet ultrastructure
(262). In addition to the chaplins, there are two rodlin proteins
that also contribute to the development of the sheath’s rodlet
ultrastructure and the spore surface (258). Suggestively, most
of the genes for the chaplins and the two rodlin genes lie in
close proximity on the genome (263). However, the rodlins are
not required for sporulation, even though they are needed for
the sheath’s development into paired rodlet structures (258). It
is clear that these hydrophobic structural proteins play key
roles in the aerial development of streptomycetes, but the pre-
cise role of each of the individual components remains to be
resolved.
In addition to ChpE and ChpH, the onset of aerial growth
requires the extracellular accumulation of yet another hydro-
phobic surfactant, SapB (230, 264). SapB-type proteins are
widespread in streptomycetes; well-studied examples include
AmfS in S. griseus and SapT in S. tendae (265, 266). In S. coelicolor,
SapB is encoded by the ramS gene in the ramCSAB gene cluster
(196, 267), which is controlled by the orphan response regulatory
gene ramR (268–270). In turn, at least in S. griseus, transcription of
the amf operon, and thus of amfS, depends onAdpA and therefore
ultimately also on BldA (215). RamS is produced as a 42-aa pro-
peptide that is subsequently modified and exported in a way very
similar to that for lantibiotics, although the way the propeptide is
processed is yet unknown. During modification by RamC, four
dehydroalanine residues and two lanthionine bridges are intro-
duced (271). Thus, a highly modified 21-aa molecule of 2,027 Da
is produced (271), with all the structural and genetic features of
type II lantibiotics (259, 272). Despite the exciting insights that
have been obtained into the biological role of SapB so far, the
precisemechanismbywhich it controls the developmental growth
of streptomycetes awaits further elucidation, as do the transcrip-
tional and posttranscriptional control mechanisms underlying its
biosynthesis (273).
As a final comment on this topic, it is important to note that
even the extracellular addition of the fungal hydrophobin SC3
(obtained from the basidiomycete Schizophyllum commune) re-
stores aerial growth to several bld mutants of S. coelicolor that are
deficient in the production of chaplins and/or SapB (264, 265).
FIG 5 Scanning electron micrograph of the surface layer of mature spores, revealing a distinctive rodlet layer. This layer consists of hydrophobic chaplin (Chp)
and rodlin (Rdl) proteins. Bar, 100 nm.
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This again underlines the importance of the extracellular accumu-
lation of a hydrophobic layer for the early stages of aerial growth.
From Aerial Hyphae to Spores: Sporulation-Speciﬁc Cell
Division and the Cytoskeleton
Like vegetative hyphae, aerial hyphae grow by tip extension. Once
sufficient aerial biomass is generated, a signal is transmitted that
results in growth cessation, followed by the onset of sporulation.
The signal for growth cessation is not yet known but likely relates
to theWhi regulatory proteinsWhiA andWhiB, as well as the cell
division activator SsgB. Mutations of whiA and whiB produce
identical phenotypes, with hypercoiling and very long aerial hy-
phae that fail to initiate cell division (23, 174, 274), while ssgB
mutations produce a large colony phenotype, forming an ex-
tremely large aerial biomass (275).
The landmark event in the onset of sporulation is the initiation
of sporulation-specific cell division, which is notable because the
process of cell division is completely different between vegetative
and aerial hyphae.Wonderfulmovies of septum formation during
early growth of the hyphae of S. coelicolor show how irregular the
placement of septa is in vegetative hyphae, with cross-walls divid-
ing the vegetative hyphae into multigenomic compartments
(276). In contrast, during sporulation-specific cell division in aer-
ial hyphae, many septa are formed almost simultaneously and in a
highly symmetrical fashion, followed by the formation of spore
compartments and cell fission, resulting in chains of spores that
each contain a single copy of the chromosome (reviewed in refer-
ences 277 and 278). Most bacteria divide by binary fission,
whereby a single mother cell symmetrically divides into identical
daughter cells. This process involves the formation of a cytokinetic
ring structure, of which the scaffold is formed by the polymeriza-
tion of thousands of copies of the tubulin homolog FtsZ at divi-
sion sites (279–283). However, in streptomycetes, the long aerial
hyphae differentiate into chains of spores after a uniquely coordi-
nated cell division event. Distinctive ladders of FtsZ are thereby
produced that consist of up to 100 septa, and this eventually leads
to the production of chains of haploid spores (284–286). Suffi-
cient accumulation of FtsZ is required to support sporulation, and
developmental ftsZ transcription is largely dependent on the
“early” whi regulatory genes whiA, whiB, whiG, whiH, whiI, and
whiJ (287). Consistent with the notion that the control of ftsZ
transcription may be a key event, at least in S. coelicolor, the non-
sporulating phenotype of many of these early whi mutants could
be overruled by constitutive expression of ftsZ during develop-
ment (288). This also suggests that no other genes that are re-
quired for sporulation completely depend on these whi genes, at
least not when FtsZ is overexpressed.
A unique feature of Streptomyces biology is that cell division is
not required for growth and ftsZ null mutants are viable (289).
While the ftsZ mutant also fails to make cross-walls, most of the
other cell division mutants are only defective in sporulation-spe-
cific cell division (278, 290–293). This illustrates a major differ-
ence between vegetative and aerial cell division.
While sporulation-specific cell division is mechanistically very
similar to that in bacteria that divide by binary fission, the way
septum site localization is controlled is completely different, in-
volving actinomycete-specific proteins (177, 277, 278). In unicel-
lular bacteria, the positioning and timing of the formation of a
septum involves the action of negative-control systems such as
Min, which prevents Z-ring assembly at the cell poles (294, 295),
and nucleoid occlusion, which prevents DNAdamage by blocking
Z-ring formation over nonsegregated chromosomes (296). The
Z-ring is tethered to the membrane by dedicated anchoring pro-
teins, such as FtsA and ZipA in Escherichia coli (297, 298). All of
these systems are absent in streptomycetes. It is therefore unclear
how streptomycetes avoid DNA damage in the multinucleoid hy-
phae. Elegant work on DNA partitioning revealed the important
role of the ParAB proteins in DNA segregation during growth and
development (299–301). FtsK helps to avoid “guillotining” of the
DNA by pumping chromosomes into the spore compartments
prior to septum closure, and ftsK mutants frequently generate
spores with incomplete chromosomes (302–304). Other proteins
that should be considered are SmeA and SffA, which play key roles
in DNA translocation during sporulation (302), and also the
DNA-packaging proteins HupS (305), sIHF (306, 307), Smc
(308), and Dps (309).
In terms of septum site localization, a key role is played by the
SsgA-like proteins (SALPs), which only occur in sporulating acti-
nobacteria (310, 311). SsgA activates sporulation-specific cell di-
vision (312, 313), and both ssgA and ssgB are required for sporu-
lation (275, 314, 315). The symmetrical spacing of the many
Z-rings is achieved by SsgB, which directly recruits FtsZ and also
stimulates its polymerization (316). SsgB localizes to future divi-
sion sites prior to and independent of FtsZ (316). Thus, cell divi-
sion is positively controlled in streptomycetes (Fig. 6). The next
obvious question is how SsgB itself is localized, especially given
that it lacks amembrane domain. Another important cell division
protein that controls sporulation-specific cell division in Strepto-
FIG 6 Model for the control of sporulation-specific cell division in Strepto-
myces. When sporulation starts, SsgA localizes dynamically in young aerial
hyphae, while SsgB and FtsZ are still diffuse at this stge. At this point, ParA is
constrained to the hyphal tip. During early cell division, SsgA and SsgB colo-
calize temporarily at either side of the aerial hyphae, with ParA extending
downward as filaments along the aerial hypha. ParB complexes are then
formed over the uncondensed chromosomes, while FtsZ assembles in spiral-
like filaments. Subsequently, FtsZ and SsgB colocalize and stay together until
FtsZ disperses, whereby SsgB recruits FtsZ and stimulate its polymerization
into protofilaments. The way the SsgB-FtsZ complex is tethered to the mem-
brane in the absence of a membrane domain in either protein is unclear, but a
likely role is played by the SepG protein (SCO2078 in S. coelicolor) encoded by
a gene upstream of divIVA (L. Zhang, J. Willemse, D. Claessen, and G. P. van
Wezel, unpublished data). Z-rings are then formed at the sporulation stage,
followed by chromosome condensation and segregation and the production of
sporulation septa. SsgA eventually marks the future germination sites. The
figure was adapted from references 277 and 316.
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myces is CrgA, which affects sporulation-specific cell division by
influencing Z-ring assembly (317). In contrast to the SALPs, CrgA
also occurs in nonsporulating actinomycetes, and it interacts with
FtsZ, FtsI, and FtsQ inMycobacteria (318). The phenotypes of crgA
null mutants and overexpressing strains suggest that CrgA affects
both cell division and the cytoskeleton, although its precise mode
of action is still unknown.
Streptomycetes probably have amuchmore elaborate cytoskel-
eton than most other bacteria, which may be explained by their
hyphal rather than planktonic growth (319). Besides the tubulin
homolog FtsZ and the actin-like proteins MreB and Mbl (320,
321), a large number of proteins with coiled-coil structural ele-
ments occur in these bacteria, and evidence is accumulating re-
garding their important role in growth, cell shape, and morpho-
genesis (319, 322–324). The protein FilP forms intermediate
filament-like structures that contribute to mechanical stress resis-
tance (322). In addition, the Scy protein, encoded by a gene im-
mediately adjacent to filP, apparently functions as a “molecular
assembler” and sequesters DivIVA (323). DivIVA is essential for
growth in streptomycetes and localizes to tips to drive apical
growth, although the molecular mechanism of this process is still
unclear (325, 326). In this way, Scy establishes growth nuclei for
apical growth and branching. It also interacts with the chromo-
some-partitioning protein ParA (327) and the intermediate fila-
ment-like protein FilP, which in turn interacts with DivIVA. The
apical assembly that drives tip growth was termed the tip organiz-
ing complex (TIPOC) by Gabriella Kelemen and colleagues (323,
328, 329). SsgA (330) and the polysaccharide synthase CslA (323,
328, 329) are other proteins that are part of this TIPOC. Clearly,
we can only see the tip of the iceberg at present, and future discov-
eries will undoubtedly shed new light on these processes.
STREPTOMYCETES AS ANTIBIOTIC FACTORIES
Actinomycetes produce approximately two-thirds of all known
antibiotics, themajority of which are produced by streptomycetes.
Consequently, these microorganisms are very important in the
fight against emerging multidrug-resistant pathogens (331–333).
Streptomyces coelicolor is a model system for studying (the control
of) antibiotic production. Scientists have marveled for decades at
the ability of single streptomycetes species to produce a plethora of
different antibiotic compounds. For example, those produced by
S. coelicolor include actinorhodin (Act [334]), undecylprodigiosin
(Red [335]), calcium-dependent antibiotic (CDA [336]), and
methylenomycin (Mmy [337]), the latter of which is carried on a
plasmid. However, when the genome sequence of S. coelicolorwas
published (263), it became apparent that this species’ true poten-
tial as a producer of natural products had actually been underes-
timated: over 20 biosynthetic gene clusters for secondary metab-
olites were identified (338), including one that appears to be for
the production of a cryptic polyketide antibiotic (Cpk [339]). It
rapidly became apparent that such “concealment” of antibiotic-
producing capabilities is the norm rather than the exception, with
some streptomycetes harboring more than 50 different secondary
metabolite gene clusters (340–343). It therefore appears that the
potential of these organisms for novel drug production is much
greater than originally anticipated. This has prompted extensive
research in applied genomics into so-called cryptic, silent, or
sleeping antibiotics (reviewed in references 344 to 347) andmeth-
ods for activating their biosynthesis (348–352).
Correlation between Growth and Antibiotic Production
Programmed cell death and theDasR system.The production of
antibiotics (and other secondary metabolites) is temporally cor-
related to the onset of development in the Streptomyces life cycle
(179, 180). This correlation may exist because of the need to de-
fend the colony when it is undergoing PCD. Evidence supporting
such a direct link between PCD and antibiotic production was
provided by the observation that cell wall-derived N-acetylgluco-
samine (GlcNAc) acts as a signal for the onset of development and
as a global elicitor molecule for antibiotic production (186, 187).
In competitive soil habitats, the timing of development is crucial.
However, it is not clear how colonies know when to initiate this
process, which has such major consequences for the colony. As
long as sufficient nutrients are available, growth should prevail
over development, while during starvation, sporulation and sub-
sequent spore dispersal are essential for the survival of the prog-
eny. The signals that trigger such events should be unmistakable,
andGlcNAcmay serve this purposewell. In nature,GlcNAc can be
obtained from hydrolysis of the abundant natural polymer chitin
by the chitinolytic system, or from hydrolysis of microorganism
cell walls. For bacteria, GlcNAc is a favorable C and N source and
a major constituent of the cell wall peptidoglycan. Some 13 chiti-
nases and chitosanases have been identified in S. coelicolor (353–
355).
Interestingly, under poor nutritional conditions, supplement-
ing with GlcNAc accelerates both the onset of development and
antibiotic production, suggesting that under these conditions
GlcNAc signals nutrient stress, resulting in accelerated develop-
ment. Conversely, in richmedia, higher concentrations ofGlcNAc
block development and antibiotic production, thus inducing a
response typical of vegetative growth (187). The different growth
conditions of minimal and rich media likely resemble conditions
of feast or famine in the natural environment (i.e., the soil), with
GlcNAc acting as an important signaling molecule that would
typically be derived from chitin in nutrient-rich soil during feast
periods or from the Streptomyces cell walls during PCD (famine),
respectively. The secret of this dual signaling role appears to lie in
the nature of the sugar transporters. Monomeric GlcNAc enters
the cell via the NagE2 permease (356), which is part of the PEP-
dependent phosphotransferase system (PTS) (357, 358), while
chitobiose (dimeric GlcNAc), which is the subunit of chitin, en-
ters via the ABC transporters DasABC orNgcEFG (241, 353, 359).
Subsequently, internalized GlcNAc is converted by the enzymes
NagA andNagB to glucosamine-6-phosphate (GlcN-6-P) (360), a
central metabolite that can then enter glycolysis (as fructose-6P)
or the pathway toward peptidoglycan synthesis.
GlcNAc-derived GlcN-6-P acts as an allosteric effector of the
GntR family regulator DasR (186), a global regulator that controls
the GlcNAc regulon (186, 360, 361), and also the production of
antibiotics (187) and siderophores (362). GlcNAc-dependent nu-
tritional signaling is most likely mediated through changes in the
intracellular level ofGlcN-6-P,which binds as a ligand to theGntR
family regulator DasR, leading to derepression of DasR-mediated
control of antibiotic production (187). As shown by genome-wide
transcription and ChIP-on-chip analysis, all pathway-specific ac-
tivator genes for antibiotic biosynthetic gene clusters are con-
trolled by DasR (363). Thus, antibiotic biosynthesis and secretion
is induced by adding GlcNAc to minimal medium with a poor
carbon source. As mentioned above, these conditions activated
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the cpk gene cluster (187), which encodes genes that for the cryptic
polyketide Cpk and was more recently established as coelimycin
P1 (364). This suggests that similar conditions could be used to
activate other cryptic antibiotic gene clusters which are expressed
poorly (or not at all) under normal growth conditions.
It was recently shown that “hostile” interactions between
streptomycetes such as antibiosis and suppression of production
by competitors primarily occur under nutrient-limiting condi-
tions; conversely, under nutrient-rich conditions, social interac-
tions are favored (365). These observations suggest that antibiot-
ics are indeed used as weapons in nature. This concept is in
contrast with studies suggesting that antibiotics act as signals for
intercellular communication (366–368). The latter hypothesis is
based on the rationale that the secreted antibiotics may not reach
sufficiently high concentrations to cause appreciable growth inhi-
bition and the observation that subinhibitory concentrations of
antibiotics induce responses such as biofilm formation (369) or
virulence (370) that may benefit the target cells (371). In terms of
concentrations in the soil, the same argument can be made for
GlcNAc, which only activates antibiotic production at millimolar
concentrations on agar plates. Presumably, small molecules reach
higher local concentrations, for instance, in close proximity to a
producing colony or, in the case of natural products, by binding to
dead plant or animal material. In this context, it is worth remem-
bering that cellulose is a preferred columnmaterial for the purifi-
cation of natural products. Information on the interactions be-
tween microbes is not just of ecological and evolutionary
importance, since it could also be useful in drug discovery efforts.
Indeed, data on the interactions between microbes could provide
key clues concerning the activation of cryptic biosynthetic path-
ways (372–376).
Stringent control. As discussed, nutrient deprivation and the
resulting growth cessation are the primary triggers for the onset of
antibiotic production. Starvation results in the depletion of amino
acids and hence uncharged tRNAs, which then occupy the ribo-
somal A-site. This in turn induces the production of the small
molecules guanosine tetraphosphate and pentaphosphate (377).
However, (p)ppGpp, or “magic spot,” as it was originally known,
is produced in response to basically all processes that relate to
changes in nutrient availability and might affect growth, adapta-
tion, secondary metabolism, survival, persistence, cell division,
motility, biofilm formation, development, competence, and viru-
lence (378). The synthesis of (p)ppGpp fromGTP andATP can be
carried out by either RelA, which is ribosome associated and acti-
vated by the binding of uncharged tRNAs to the ribosome, or by
SpoT, which produces (p)ppGpp in response to nutrient starva-
tion (378). The ribosomal protein L11, encoded by rplI (relC),
activates RelA and thus ppGpp synthesis (379). Deletion of the
relA gene suppresses antibiotic production, underlining the im-
portant role of the stringent response in controlling antibiotic
production (380). Indeed, under nitrogen-limiting conditions
ppGpp causes a dramatic switch in the physiology of streptomy-
cetes, activating the expression of genes involved in morphologi-
cal and chemical differentiation, including the production ofCDA
and actinorhodin, and at the same time repressing genes involved
in normal growth (381). The exact mechanism by which ppGpp
acts upon such a wide range of genes remains to be elucidated.
However, the response to fatty acid starvation involves the direct
binding of the unacylated (“uncharged”) fatty acid acyl carrier
protein (ACP) to SpoT (382), and it has been suggested (180) that
perhaps theACPs of polyketide synthases help to control the strin-
gent response in a similar fashion, providing a possible explana-
tion of the relationship between the stringent response and sec-
ondary metabolism.
Morphological control.A complex relationship exists between
morphology and antibiotic production. Streptomycetes display a
great many different morphologies in submerged cultures, rang-
ing from fragmented growth to dense clumps, and this can have a
major influence on their production levels (24). For example, in
Saccharopolyspora erythraea, erythromycin production is favored
by clumps with a minimum size of around 90 m in diameter
(383). The connection betweenmycelialmorphology andproduc-
tion is further exemplified by avermectin production by S. aver-
mitilis, which is favored by small dense pellets (384), and by S.
coelicolor, in which forced fragmentation by overexpression of the
cell division activator protein SsgA abolishes actinorhodin pro-
duction. However, it is dangerous to generalize, as the same strain
shows a 20- to 50-fold increase in undecylprodigiosin production
in a fermentor (310, 313, 315), and chloramphenicol production
by Streptomyces venezuelae is not hampered by the extremely frag-
mented growth of the producing organism (385, 386). It was pre-
viously suggested that antibiotics that are produced during expo-
nential growth may benefit from fragmented growth, while those
produced during the transition or stationary phases are produced
much more efficiently by clumps (236).
More insights into the genetic factors that control mycelial
growth should allow scientists to significantly improve the yield of
natural product formation by actinomycetes. A novel set of genes
was recently discovered in Streptomyces that control pellet growth,
calledmat, for mycelial aggregation (387). The genes were discov-
ered 30 years ago via reverse engineering of a strain of S. lividans
that was selected for fragmented growth in a chemostat (388).
Deletion of themat genes (SCO2962 and SCO2963 in S. coelicolor)
prevented pellet formation and increased both growth rate and
enzyme production in S. lividans (387). The mat genes are prob-
ably responsible for the production of a secreted polysaccharide,
which presumably glues the hyphae together and thus promotes
pellet aggregation.
In silicomodels have been developed to better understandmy-
celial growth (389–391), although many were primarily based on
physiological and nutritional parameters. Helped by the strong
increase in computing power in themodern era, newmodels were
developed recently (392, 393). In particular, a three-dimensional
model was developed that includes parameters such as hyphal
growth, branching, fragmentation, cross-wall formation, and col-
lision detection, as well as oxygen diffusion (392). For the rational
design of actinomycetes as production hosts, it is imperative that
we better understand how morphology correlates with produc-
tion. For example, when and especially where are natural products
(and enzymes) secreted? Secretion at apical sites would imply that
fragmented growth is favorable because it increases the number of
hyphal tips per length unit, as opposed to when production pri-
marily takes place inside mycelial clumps. Interestingly, produc-
tion of enzymes through the twin arginine translocation (Tat)
exporter occurs closely behind the hyphal tips in S. coelicolor (16,
394); in line with this concept, Tat substrates are secreted more
efficiently in fragmenting strains of S. coelicolor and S. lividans
(313). An extensive review of the industrial implications of the
correlation between growth and natural product formation is be-
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yond the scope of this review, so we refer the interested reader
elsewhere (24, 395–398).
Fromglobal control to the activation of specific gene clusters.
The global regulatory networks ultimately relay information to-
ward the individual biosynthetic gene clusters, acting at the level
of pathway-specific control. Transcription of antibiotic biosyn-
thetic gene clusters typically depends on a pathway-specific acti-
vator gene inside the cluster. Many of these are controlled in a
growth phase-dependent manner, with the SARP family regula-
tors (399) being the best-known examples. Particularly well-
known members of this family are ActII-ORF4 and RedD, which
activate the production of the pigmented antibiotics actinorhodin
and undecylprodigiosin, respectively, in S. coelicolor, and StrR for
production of the aminoglycoside streptomycin in S. griseus (400–
402). As exemplified by the actinorhodin biosynthetic activator
gene actII-ORF4, transcription of which is controlled by over 15
different regulatory proteins, the timing and accumulation of a
pathway-specific activator may be very complex (236, 395). How-
ever, once activated, there appears to be little additional control
downstream, as long as the necessary precursors are present. In-
deed, when redD, the pathway-specific activator gene for produc-
tion of prodigionines in S. coelicolor, is placed under the control of
another regulatory element, the result is that control of prodi-
gionin production becomes dictated by the regulatory network
controlling that element (275, 314, 315). In other words, placing
redD under the control of the promoter for the global nitrogen
regulator (glnR) or the sporulation-specific sigma factor (sigF)
ensures that production is controlled by nitrogen or produced in
aerial hyphae, respectively. This implies that there may be few
genetic limitations regarding the production of natural products
in time and space once an appropriate activator is expressed. From
a production point of view this is an advantage, because restric-
tions due to growth phase-related control mechanisms can be
dealt with by changing the regulatory element. This is particularly
important for heterologous expression of biosynthetic gene clus-
ters that are being uncovered at a high rate in actinomycetes in the
era of genome sequencing. In particular, the combination of syn-
thetic biology approaches with expression in optimized heterolo-
gous Streptomyces production platforms is a promising develop-
ment (403–408).
ACTINOBACTERIA AS SOURCES OF NATURAL PRODUCTS
Actinobacteria as Sources of Antibiotics
Actinobacteria are of great importance in the field of biotechnol-
ogy, as producers of a plethora of bioactive secondary metabolites
with extensive industrial, medical, and agricultural applications
(Table 3 provides examples and corresonding references). In par-
ticular, Actinobacteria produce the majority of the naturally oc-
curring antibiotics. The first antibiotics discovered in Actinobac-
teriawere actinomycin from a culture of Streptomyces antibioticus
in 1940 (409), streptothricin from Streptomyces lavendulae in 1942
(410), and streptomycin from Streptomyces griseus in 1944 (411),
all of which were discovered by Waksman and colleagues. Strep-
tomycetes have been the major source of clinical antibiotics and
are responsible for over 80% of all antibiotics of actinobacterial
origin (333). That actinomycin, streptomycin, and streptothricin
were the first to be found is not surprising, as these molecules
occur atmuchhigher frequencies thanmany other antibiotics. For
example, streptothricin is found in some 10% of all streptomyce-
tes isolated randomly from soil and streptomycin is found in 1%
and actinomycin in 0.1%, while conversely, erythromycin and
vancomycin are found in around 105 soil isolates, and daptomy-
cin is found only at a frequency of around 107 (412). Major
classes of clinical antibiotics produced by actinomycetes are the
following: aminoglycosides (neomycin, kanamycin, streptomycin
(413–415), angucyclines (auricin; also, antitumor agents like lan-
domycin andmoromycin (416), ansamycins (rifamycin, geldana-
mycin) (417), anthracyclines (primarily antitumor agents, e.g.,
daunorubicin) (418, 419), -lactams (cephamycins) (420) and
also the important -lactamase inhibitor clavulanic acid (421,
422), chloramphenicol (423), glutarimides (cycloheximide)
(424), glycopeptides (vancomycin, teichoplanin) (425, 426), lipo-
peptides (daptomycin) (427), lantibiotics (mersacidin, actagar-
dine) (272), macrolides (clarythromycin, erythromycin, tylosin,
clarithromycin) (428, 429), oxazolidinones (cycloserine) (430),
streptogramins (streptogramin) (431), and tetracyclines (432).
The producing capacity of individual actinomycetes can also vary
enormously. Some Streptomyces species produce a single antibi-
otic, while others produce a range of different compounds and
compound classes.
Besides antibiotics,Actinobacteria also produce awide variety of
other secondary metabolites with activity as herbicides (54), anti-
fungals, antitumor or immunosuppressant drugs, and anthel-
mintic agents (433). Examples are given below.
Actinobacteria as Sources of Insecticides
Macrotetrolides are active against mites, insects (434–436), coc-
cidia (437), and helminths (438), and they also show immunosup-
pressive effects (439). They are produced by a variety of Strepto-
myces species (for a review, see Jizba et al. [434]). However, with
regard to the composition of the macrotetrolide complex, only S.
aureus S-3466 (440), which produces amixture of tetranactin (the
most active member of the compound group) with dinactin and
trinactin (435, 441), has been utilized for commercial purposes
(442). Tetranactin, a cyclic antibiotic produced by Streptomyces
aureus with a molecular structure related to cyclosporine, is used as
emulsion against carminemites of fruits and tea. A true success story
in terms of anthelmintics is ivermectin (443), which is a dehydro
derivative of avermectin produced by Streptomyces avermitilis. After
its appearance in the late 1970s, ivermectin was the world’s first en-
dectocide, which at the time was a completely novel class of antipar-
asitic agents, with strong and broad-spectrum activity against both
internal andexternalnematodes andarthropods.Recently, theNobel
Prize for Physiology or Medicine 2015 was awarded to Satoshi
Omura and William C. Campbell for their discovery of avermectin,
jointly with Youyou Tu for the discovery of the antimalarial drug
artemisinin.
Actinobacteria as Sources of Bioherbicide and Bioinsecticide
Agents
Mildiomycin, an antifungal metabolite isolated from cultures of
Streptoverticillium rimofaciensNiida, is strongly active against sev-
eral powdery mildews on various crops (444) and inhibits fungal
protein biosynthesis (445). The primary sites of action of these
antibiotics are at locations where chitin synthesis occurs in the cell
wall, there is cation leakage from mitochondria, inositol biosyn-
thesis is occurring, or sites of protein and DNA synthesis. The
compounds mentioned above are a few examples of agroactive
compounds isolated from Actinobacteria. Validamycin A was
Barka et al.
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TABLE 3 Examples of bioactive molecules produced by Actinobacteria genera and their activities
Type of compound and producing species Bioactive agent(s) Source or reference
Antibacterial agent producers
Verrucosispora spp. Abyssomycin 603
Streptomyces anulatus Actinomycins 409
Streptomyces canus Amphomycin 604
Micromonospora spp. Anthracyclin 605
Streptomyces cattley Antibiotics and fluorometabolites 606
Streptomyces canus Aspartocins 607
Streptomyces avermitilis Avermectin 608
Streptomyces venezuelae Chloramphenicol 609
Micromonospora spp. Clostomicins 609
Streptomyces griseus Cycloheximide 620
Streptomyces orchidaceus Cycloserine 610
Streptomyces roseosporus Daptomycin 611
Saccharopolyspora erythraea Erythromycin (Ilotycin) 612
Micromonospora purpurea Gentamicin 613
Streptomyces hygroscopicus Hygromycin 614
Streptomyces kanamyceticus Kanamycin 615
Streptomyces kitasoensis Leucomycin 616
Streptomyces lincolnensis Lincomycin 617
Marinispora spp. Marinomycin 618
Streptomyces fradiae Neomycins 619
Micromonospora spp. Netamicin 80
Streptomyces niveus Novobiocin 620
Streptomyces antibioticus Oleandomycin 621
Streptomyces rimosus Oxytetracycline 622
Streptomyces spp. Pristinamycin 623
Streptomyces lindensis Retamycin 624
Streptomyces mediterranei Rifamycin 625
Nocardia lurida Ristocetin 621
Streptomyces ambofaciens Spiramycin 626
Streptomyces virginiae Staphylomycin 627
Streptomyces endus Stendomycin 628
Streptomyces lydicus Streptolydigin 629
Streptomyces griseus Streptomycin 411
Streptomyces lavendulae Streptothricin 410
Streptomyces aureofaciens Tetracycline 630
Micromonospora spp. Thiocoraline 631
Amycolatopsis orientalis Vancomycin 632
Antifungal agent producers
Streptomyces anulatus Actinomycins 603
Streptomyces nodosus Amphotericin B 633
Streptomyces griseochromogenes Blasticidin 634
Streptomyces griseus Candicidin 635
Streptomyces spp. Carboxamycin 636
Streptomyces venezuelae Chloramphenicol 637
Streptomyces padanus Fungichromin 638
Streptomyces galbus Galbonolides 675
Streptomyces violaceusniger YCED-9 Guanidylfungin 564
Streptomyces venezuelae Jadomycin 639
Streptomyces kasugaensis Kasugamycin 452
Streptomyces spp. Kitamycin 640
Streptomyces natalensis Natamycin 641
Streptomyces tendae Nikkomycin 642
Streptomyces diastatochromogenes Oligomycin 643
Streptomyces humidus Phenylacetate 644
Streptomyces cacaoi Polyoxin B 453
Streptomyces canus Resistomycin 645
Streptomyces lavendulae Streptothricin 410
Streptomyces canus Tetracenomycin 645
Nocardia transvalensis Transvalencin 646
Streptomyces hygroscopicus Validamycin 647
(Continued on following page)
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commercialized byTakeda for the control of pathogens in rice and
other plants and as a tool for damping off diseases in vegetable
seedlings. On the other hand, some secreted metabolites are cyto-
toxic and can include chemical structures such as macrolides,
	-pyrones, lactones, indoles, terpenes, and quinones (446). For
instance, resistomycin, a quinone-related antibiotic, has a unique
structure and exhibits bactericidal and vasoconstrictive activity
based on the inhibition of RNA and protein synthesis (447, 448).
The genome sequences of important Actinobacteria species re-
ported to date indicate that as much as 90% of the chemical po-
tential of these organisms remains undiscovered and that the bio-
syntheticmachinery encoded bymany of these genetic locimay be
activatable under laboratory conditions (449). The predictive
models ofWatve et al. (450) suggested that over 150,000 bioactive
metabolites frommembers of the genus Streptomyces alone within
this order are still waiting to be discovered (328, 451). Molecular
techniques such as combinatorial biosynthesis may lead to the
discovery of drugs that cannot be found naturally and of biosyn-
thetic components that can be interchanged andmodified to pro-
duce bioactive products with unique properties.
TABLE 3 (Continued)
Type of compound and producing species Bioactive agent(s) Source or reference
Bioherbicide/biopesticide producers
Actinomadura spp. 2,4-Dihydro-4-(-D-ribofuranosyl)-1, 2, 4 (3H)-triazol-3-one (herbicide) 648
Streptomyces hygroscopicus Herbimycin 649
Streptomyces avermitilis Ivermectin (derivative of avermectin) 650
Streptomyces prasinus Prasinons 651
Saccharopolyspora spinosa Spinosad (neurotoxic insecticides) 652
Antiparasitic agent producers
Streptomyces avermitilis Avermectins 608
Streptomyces coelicolor Prodiginine 653
Streptomyces bottropensis Trioxacarcin 654
Antiviral agent producers
Streptomyces antibioticus 9--D-Arabinofuranosyladénine 655
Streptomyces hygroscopicus Hygromycin 614
Streptomyces spp. Panosialins 656
Hypercholesterolemia agent producer
Streptomyces hygroscopicus Rapamycin 674
Antitumor agent producers
Micromonospora spp. Anthraquinones 657
Nocardia asteroides Asterobactine 658
Streptomyces spp. Borrelidine 659
Micromonospora spp. Diazepinomicin 660
Actinomadura spp. IB-00208 661
Micromonospora spp. LL-E33288 complex 76
Micromonospora spp. Lomaiviticins 76
Micromonospora spp. Lupinacidins 657
Thermoactinomyces spp. Mechercharmycin 662
Marinospora spp. Marinomycin 618
Salinispora tropica Salinosporamide 621
Streptomyces peucetius Doxorubicin (adriamycin) 664
Streptomyces peucetius Daunorubicin (daunomycin) 665
Micromonospora spp. Tetrocarcin 76
Micromonospora spp. Thiocoraline 666
Immunostimulatory agent producers
Nocardia rubra Rubratin 667
Streptomyces olivoreticuli Bestatin 668
Kitasatospora kifunense FR-900494 669
Immunosuppressive agent producers
Nocardia brasiliensis Brasilicardin 670
Streptomyces filipinensis Hygromycin 671
Streptomyces filipinensis Pentalenolactone 671
Therapeutic enzyme (antitumor) producers
Streptomyces spp. L-Asparaginase 672
Streptomyces olivochromogenes L-Glutaminase 673
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Actinobacteria as Sources of Antifungal Agents
Kasugamycin is a bactericidal and fungicidal metabolite secreted
by Streptomyces kasugaensis (452) that acts as an inhibitor of pro-
tein biosynthesis in microorganisms but not in mammals. The
systemically active kasugamycinwasmarketed to control rice blast
(Pyricularia oryzae cavara) and bacterial Pseudomonas diseases in
several crops. In 1965, Isono et al. (453) isolated the first members
of a new class of natural fungicides, polyoxins B and D, from
metabolites of Streptomyces cacaoi var. asoensis. These substances
act by interfering with fungal cell wall synthesis by inhibiting chi-
tin synthase (454). Polyoxin B is applied against a number of fun-
gal pathogens in fruits, vegetables, and ornamentals, while
polyoxin D is used to control the causative agent of rice sheath
blight, Rhizoctonia solani (455).
In 1968, the validamycin family was detected by researchers at
Takeda Chemical Industries in a greenhouse assay for the treat-
ment of sheath blight disease in rice plants caused by the fungus
Rhizoctonia solani. Validamycin A, the major and most active
component of the complex, was isolated from Streptomyces hygro-
scopicus var. limoneus. Within the fungal cell, validamycin is con-
verted to validoxylamine A, a particularly strong inhibitor of tre-
halose that suppresses the breakdown of intracellular trehalose
(456). Trehalose is well known as a storage carbohydrate, and
trehalase plays an essential role in the transport of glucose in in-
sects and fungi (457). This mode of action gives validamycin A a
favorable biological selectivity, since vertebrates do not depend on
the hydrolysis of the disaccharide trehalose for their metabolism
(457).
INTERACTIONS BETWEEN ACTINOBACTERIA AND OTHER
ORGANISMS
Interactions between Actinobacteria and Invertebrates
Insect-bacterium symbioses are widespread in the environment
(458), and antibiotic-producing bacterial symbionts are often re-
cruited to protect the host and/or their resources (459, 460).Many
insects (e.g., ants, termites, gall midges, and beetles) have devel-
oped a specific association with their microbial communities.
These interactions are diverse, ranging from antagonism and
commensalism to mutualism, and from obligate to facultative
(461).
Interaction with ants.Microbial communities of many groups
of insects have been widely studied (462), and particularly com-
plex associations have been documented between gut bacteria and
insects (463, 464). Attine ants have evolved a mutualism with Ac-
tinobacteria that produce antibiotics that the ants use as weedkill-
ers to keep their fungal gardens free of other microbes (460, 465).
For instance, the ants (genera Atta and Acromyrmex) cut leaves
and then masticate them into a fine biomass that is fed to the
symbiotic fungus (Leucoagaricus gongylophorus) which, in turn,
provides lipid- and carbohydrate-rich hyphae known as gongy-
lidia that will be used by the ants (466).
The ants rely on a similar mutualistic association with mem-
bers of the Actinobacteria (genus Pseudonocardia) that produce
antibiotics that help suppress Escovopsis, which has a devastating
effect on the fungus gardens of leaf-cutting ants in the absence of
the bacterium (467–470), by significantly reducing the colony fit-
ness or even inducing colony death (471). Other Actinobacteria
generamay play a similar role (472, 473). The presence andmain-
tenance of Streptomyces bacteria seems to be of prime importance,
as the bacteria appear to be the primary defense against Escovopsis,
which ants possess (467, 474).
Interactions with beetles. Multiple bacterial genera of the
Gammaproteobacteria andActinobacteria classeswere found in the
larvae, pupae, and adult guts of the bark beetle Dendroctonus rhi-
zophagus. The class of Actinobacteriawas represented by Ponticoc-
cus gilvus and Kocuria marina, both of which can degrade car-
boxymethylcellulose in vitro. Neither Actinobacteria species has
ever been reported in other bark beetles, suggesting that these
bacteria could be involved in the degradation of cellulosic sub-
strates such as pine bark and phloem, enabling them to serve as a
carbon source (475). This postulate is supported by the presence
of cellulose-degrading bacteria in the gut of insects that feed on
woody tree tissues, such as wood-boring beetles, including
Saperda vestita and Agrilus planipennis (476, 477).
Interactions with protozoans. Mycobacterium ulcerans is re-
sponsible for a necrotizing cutaneous infection called Buruli ulcer,
which has been reported in more than 30 countries worldwide,
mainly in tropical and subtropical climates. However,M. ulcerans
can probably not live freely due to its natural fragility, slow-
growth development, and inability towithstand exposure to direct
sunlight. Further, M. ulcerans is sensitive to several antibiotics,
such as streptomycin and rifampin. M. ulcerans therefore rarely
occurs as a free-living microorganism, even though Streptomyces
griseus andAmycolatopsis rifamycinica, producers of streptomycin
and rifampin, thrive under such conditions (478, 479).
To survive, Mycobacterium has adapted to a more protected
niche by utilizing free-living amoebae (FLA) as carriers. In their
protozoan hosts, “hidden”mycobacteria might find easier oppor-
tunities to infect vertebrate end hosts, multiplying within proto-
zoans to escape immune reactions (480). This ability to persist
within amoebae has been widely documented (481–483). The in-
ternalization of infectious agents inside other parasites represents
an evolutionary strategy for survival that may sometimes enhance
pathogenesis or transmissibility (480).
Interactions between Actinobacteria and Vertebrates
Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria, and Proteo-
bacteria dominate the gut microbiota, demonstrating a similar
overall composition at the phylum level in various gastrointestinal
tract locations, including human gastric fluid, intraoral niches
(484, 485), throat (486), distal esophagus (487), stomach mucosa
(486), and feces (488). Further, Actinobacteria are prominent
among the identified microbiota of the oral cavity but are signifi-
cantly less abundant in the lower gastrointestinal and genital
tracts.
Children with diabetes reportedly exhibit substantially lower
numbers of Actinobacteria and Firmicutes compared to healthy
children. Further, within the Actinobacteria, the number of Bifi-
dobacterium was significantly lower in children with diabetes
(489).
Metagenomic studies of mucosal and fecal samples retrieved
from healthy subjects demonstrated the presence of six dominant
phylogenetic phyla, including Actinobacteria (490). The role of
bifidobacteria in gut ecology illustrates the importance of Actino-
myces and other Actinobacteria (491). The phyla Actinobacteria,
Bacteroidetes, Firmicutes, Fusobacteria, and Proteobacteria consti-
tute more than 99% of all gut microbiota in dogs and cats. Com-
pared with the case in humans, which harbor 1018 bacterial cells,
Bifidobacteria is less abundant in cats and dogs (492, 493).
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Although the aerobic Actinobacteria are infrequently encoun-
tered in clinical practice, they are important potential causes of
serious human and animal infections. These bacteria have
emerged as unusual but important potential human pathogens
that cause significant disease, affecting not only immunocompe-
tent hosts but also severely immunocompromised patients. Mc-
Neil and Brown (494) reviewed the data on medically important
aerobicActinobacteria and epidemic diseases that these organisms
cause in animals and humans. For instance, the genus Nocardia
comprises several species that are known to be unusual causes of a
wide spectrum of clinical diseases in both humans and animals,
infecting cattle, horses, dogs, and swine (494). While the majority
of nocardial infections have been attributed toNocardia asteroides,
other pathogenic Nocardia species that have been reported in-
cludeN. brasiliensis,N. otitidiscaviarum, andN. transvalensis. In a
taxonomic revision of theN. asteroides taxon, two new species,N.
farcinica and Nocardia nova, were separated (495).
Reports of human infection with Rhodococcus spp. have been
rare (494). The disease they cause can have a variable clinical pre-
sentation depending upon the host’s underlying immune status
and possibly upon the site of inoculation and the virulence of the
infecting microorganism. Consequently, in severely immuno-
compromised patients, primary pulmonary Rhodococcus equi in-
fections (pneumonia and lung abscesses) have been reportedmost
frequently (494).
Only a few invasive humans infections, such as mycetoma
caused by Streptomyces spp., have been documented to date (496).
They can, however, be caused by S. somaliensis and S. sudanensis
(497, 498). The majority of invasive Streptomyces infections are
associated with bacteremia and lung infections, namely, pneumo-
nia, abscess, and pneumonitis (499). Streptomycetes are infre-
quent pathogens, although S. somaliensis and S. sudanensis can
cause infections.
As for Rhodococcus, most of the infected patients had some un-
derlying immunosuppressive condition, such as HIV infection,
cancer, systemic lupus erythematosus (SLE), Crohn’s disease, etc.
Moreover, S. pelletieri, S. griseus, S. lanatus, and S. albus have been
isolated from various patients with lung pathology (496, 500–
502). Other opportunistic pathogenic Actinobacteria include
Amycolata autotrophica, A. orientalis, Micromonospora spp., N.
dassonvillei, and Oerskovia spp. (494).
Interactions between Actinobacteria and Plants
As stated previously, actinomycetes are abundantly present in
soils and represent a high proportion of the microbial flora of the
rhizosphere (503).Actinobacteria thus unsurprisingly play diverse
roles in plant-associatedmicrobial communities. Some genera are
viewed predominantly as soil saprophytes with crucial roles in
nutrient cycling, while others are endophytes, beneficial symbi-
onts, or even pathogens of plants.
Plant-Actinobacteria deleterious interactions. (i) Actinobac-
teria as plant pathogens.The successful infection of a plant host is
a complex multistep process, requiring the pathogen to sense the
presence of a suitable host, penetrate and colonize the plant tissue,
and survive in the presence of host defense mechanisms. In com-
parison to other bacteria, actinomycetes play a relatively minor
role in plant diseases. However, they representmajor pathogens of
certain crops in particular areas, and under special conditions
affect the quality and the quantity of agricultural products. This
may result in huge agricultural losses, especially of potatoes but
also of other root crops, such as beet, carrot, parsnip, radish, sweet
potato, and turnip (504, 505).
Recent progress in molecular genetics and the understanding
of the genomics of plant pathogenicity has been made for the
Actinobacterial genera Clavibacter, Streptomyces, Leifsonia, and
Rhodococcus. Further, plant-pathogenicActinobacteria in the gen-
era Streptomyces and Rhodococcus have very wide host ranges, in-
cluding economically important crops and model plants. For in-
stance, in the genus Streptomyces, plant pathogenicity is rare, with
only a dozen or so species possessing this trait of themore than 900
species described.Nevertheless, such species have a significant im-
pact on agricultural economies throughout the world due to their
ability to cause important crop diseases, such as potato common
scab, which is characterized by lesions that form on the potato
tuber surface. The most well-known phytopathogenic Actinobac-
teria are Streptomyces scabiei, S. acidiscabies, and S. turgidiscabies,
which induce devastating scab diseases on a broad spectrum of
plants. Streptomyces scabiei, themost ancient of these pathogens, is
found worldwide, whereas S. turgidiscabies and S. acidiscabies are
emergent pathogens that were first described in Japan and the
northeastern United States, respectively (506–508).
S. scabiei and S. turgidiscabies both cause “common” scab in
potatoes (Solanum tuberosum); the disease is characterized by gray
spores borne in spiral chains and that produce melanin (509).
Another disease, the “acid scab,” is associated with S. acidiscabies
(510). The typical and acid scab strains differ with respect to pig-
mentation, spore chainmorphology, raffinose utilization, and tol-
erance of low pH. In addition, S. acidiscabies differs from S. scabiei
in phenotype and ecology by having flexuous spore chains, a
growth medium-dependent spore mass color ranging from white
to salmon-pink, a red or yellow pH-sensitive diffusible pigment,
and no melanin.
Russet scab is commonly restricted to nature of the potato’s
skin and affects the quality of the crop. This disease caused by
soilborne streptomycetes different from S. scabies has been re-
ported in Europe and the United States since the beginning of the
century (511). The disease is divided into two types. The first type
is American russet scab, caused by the genus Streptomyces and
species different from S. scabiei (which forms a pigmented myce-
lium, flexuous spore chains, and no melanin) and from S. acidis-
cabies (mass spore color, inability to grow at pH 4.5). The second
type is European russet (or netted) scab, which is apparently dis-
tinct from the American variant (512) with respect to cultivar
susceptibility, root attack, and optimum soil temperature.
No specific taxonomic investigations have been carried out on
S. ipomoeae, the causal agent of the sweet potato soil rot disease
characterized by dwarfed plants with little or no growth and mi-
nor discolored leaves, with many plants dying before the end of
the season. The organism apparently persists for long periods,
even in the absence of the host plant.
In the 1980s, Actinobacteria were reported to plug the xylem
vessels of silver, sugar, and Norway maples, leading to early decay
and dieback of the tree branches (513, 514). A variety of strepto-
mycetes of different species (S. parvus, S. sparsogenes, Streptomyces
sp.) were isolated from the plugs. The isolates were capable of
growing within the tree vessels and in vitro in the presence of
several phenols. Although sugar maples in the northeastern
United States are routinely tapped to collectmaple sap for conver-
sion tomaple syrup, themode of penetration of theActinobacteria
into the host is not known. Similarly, a lignocellulose-degrading
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streptomycete (S. flavovirens) was found to decompose the intact
cell walls of the phloem of Douglas firs, and hyphae were found in
the cavities deriving from the destruction of the walls of the pa-
renchyma and sclereids (515).
Rhodococcus fascianswas first isolated and identified in 1930 as
the causal agent of sweet pea fasciations (516). Since then, the
symptoms caused by R. fascians in diverse plant species have been
described (reviewed by Goethals et al. [517]). The bacterium in-
fects both monocot and dicot hosts, many of which are econom-
ically important (518). Extensive epiphytic growth precedes inter-
cellular invasion through stomata. R. fascians causes various
effects in its hosts, including leaf deformation and formation of
witches’ broom, fasciations, and leafy galls (517, 519). The symp-
toms are caused by the hyperinduction of shoots through activa-
tion of dormant axillary meristems and de novomeristem forma-
tion, probably as the result of elaborate manipulation of host
hormone balances and pathogen-derived auxins and cytokinins
(520, 521). In contrast to Streptomyces and Rhodococcus, plant-
pathogenic species in the Actinobacteria genera Clavibacter and
Leifsonia are host specific at the species or subspecies level.
Clavibacter michiganensis is another aerobic nonsporulating
Gram-positive plant-pathogenic member of the Actinobacteria
and is currently the only known species within the genusClavibac-
ter. C. michiganensis is composed of a number of host-specific
subspecies, all of which colonize the xylem. Currently, C. michi-
ganensis is represented by five subspecies: C. michiganensis subsp.
insidiosus,C. michiganensis subsp.michiganensis,C. michiganensis
subsp. nebraskensis, C. michiganensis subsp. sepedonicus, and C.
michiganensis subsp. tesselarius.
C. michiganensis subsp. michiganensis provokes bacterial can-
ker formation in tomatoes, a serious emerging disease of tomatoes
wherever tomato plants are grown. This disease has caused sub-
stantial economic losses worldwide (522). Another important
plant pathogen isC.michiganesis subsp. sepedonicus, which causes
a disease in potatoes known as ring rot, due to the way it rots the
vascular tissue inside potato tubers. C. michiganensis subsp. ne-
braskensis causes wilt and blight in maize. C. michiganensis subsp.
tesselarius induces leaf freckles and leaf spots inwheat.Wilting and
stunting in alfalfa (Medicago sativa) are induced byC.michiganen-
sis subsp. insidiosus (523). The severity of these diseases and the
difficulty of controlling the spread of the corresponding patho-
gens has resulted in the pathogens being classified as quarantine
organisms under the EuropeanUnion Plant Health Legislation, as
well as the laws of many other countries.
The genus Leifsonia includes xylem-limited, fastidious, bacte-
rial pathogens. The best-known of these pathogens is L. xyli subsp.
xyli, the causative agent of a systemic disease called ratoon stunt-
ing of sugarcane. Plant growth inhibition, the hallmark of this
disease, may be due to a putative fatty acid desaturase that modi-
fies the carotenoid biosynthesis pathway to produce abscisic acid,
a growth inhibitor (524).
(ii) Traits of pathogenicity.Themechanisms bywhich a patho-
gen can induce the development of lesions on the host are still not
well known, although recent advances in this field have provided
some ideas. An important feature in the interaction of a pathogen
and its host is the establishment of an equilibrium that allows both
partners to survive in nature. If no resistant or tolerant plant
cultivars are available, pathogen infection will inevitably lead to
disease outbreaks. Despite the economic importance of plant-
pathogenic Streptomyces species, very little is known about the
molecular mechanisms used by these organisms to sense the pres-
ence of a suitable plant host, colonize the host’s tissues, and resist
its defense mechanisms.
The virulence factors of C. michiganensis subsp. michiganensis
seem to be extracellular enzymes, particularly proteases. Dreier et
al. (525) reported the participation of three proteases (Pat-1,
ChpC, and ChpG) in the pathogen’s initial interactions with the
host plant, but their exact target remains unknown. Several po-
tential virulence genes are clustered in the chp-tomA region of the
bacterial genome, whichmay be a pathogenicity island and crucial
for successful colonization. It was recently shown that the viru-
lence ofClavibacter michiganensis subsp.michiganensis toward to-
mato plants can bemodulated by three differentmechanisms: loss
of plasmids accompanied by the loss of the pathogenicity factors
celA and pat-1, resulting in reduced virulence or even nonviru-
lence in a plasmid-free derivative; transfer of plasmids to plasmid-
free C. michiganensis subsp. michiganensis derivatives, which re-
stores full virulence; and loss of the pathogenicity island due to
stress-activated recA-dependent recombination events, which
leads to a low-titer colonizer that may carry the plasmids and the
pathogenicity factors necessary for effective colonization but
which can be considered a nonvirulent endophyte (526).
Ammonium assimilation and nitrogen control in M. tubercu-
losis have been studied intensively, with a particular focus on glu-
tamine synthetase I (GSI), an enzyme whose extracellular release
was identified as a potentially important determinant of pathoge-
nicity (527).
Phytotoxin production is commonly involved in the pathoge-
nicity of Streptomyces. Some early work on potato scab disease
demonstrated that darkening of tuber cells during pathogen col-
onization was a response to the action of a toxin or enzyme se-
creted by the scab organism. A key virulence determinant in scab-
causing streptomycetes is a family of phytotoxic secondary
metabolites called thaxtomins, of which thaxtomin A is the most
abundant (528). Thaxtomin production is usually positively cor-
related with pathogenicity. Further, thaxtomin induces a variety
of phenotypic changes in the plant host, including cell hypertro-
phy, root and shoot stunting, tissue necrosis, alterations in plant
Ca2 and H ion influxes, inhibition of cellulose synthesis, pro-
grammed cell death, and production of the antimicrobial plant
phytoalexin scopoletin (529–533). In addition, thaxtomin helps S.
scabiei, S. turgidiscabies, and S. acidiscabies penetrate plant cell
walls by inhibiting cellulose biosynthesis (reviewed by Loria et al.
[505]), which presumably enables the bacterium to secrete pro-
teins onto the host cell membrane. An additional virulence deter-
minant that has been described in plant-pathogenic streptomyce-
tes is a secreted necrogenic protein called Nec1. Thaxtomin and
Nec1 were the first virulence determinants to be identified and are
thought to contribute to tissue penetration and suppression of
plant defense responses, respectively. Thaxtomins are cyclic di-
peptides (2,5-diketopiperazines) derived from L-phenylalanine
and L-tryptophan, and they contain a 4-nitroindole moiety that is
essential for their phytotoxicity (528). The production of thaxto-
min A was positively correlated with disease severity (534). Mu-
tants of S. scabiei and S. acidiscabies that were deficient in thaxto-
min A biosynthesis did not cause symptoms on potato tubers,
establishing the thaxtomins as important pathogenicity determi-
nants (535, 536). Eleven family members have been isolated and
characterized and are distinguished by the presence or absence of
N-methyl and/or hydroxyl groups. Thaxtomin A, the predomi-
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nant family member produced by S. scabiei, S. turgidiscabies, and
S. acidiscabies, is required for scab disease development (536–
538). The S. scabiei coronafacic acid-like biosynthetic cluster con-
tributes to host-pathogen interactions, as demonstrated recently
by Bignell et al. (504). In addition, an extracellular esterase from S.
scabiei has been characterized, sequenced, and identified as a po-
tential virulence factor whose activity may be regulated by the
availability of zinc (539).
Several bacterial and fungal genomes have been reported to
encode proteins with distant homology to plant expansins (540).
These proteins are required for virulence, have C-terminal expan-
sin-like domains, and are found in many plant-associated micro-
organisms, including the phytopathogenic Actinobacteria organ-
isms Clavibacter michiganensis subsp. sepedonicus (526, 541). The
S. scabiei expansin-like proteins exhibit 66% homology with each
other at the amino acid level and are also closely related to putative
expansin-like proteins from two nonpathogenic Streptomyces spe-
cies. It is tempting to speculate that SCAB44951 might be impor-
tant for plant-microbe interactions, because it can mimic specific
plant PR-1 proteins and thus manipulate plant defense responses
during infection. Interestingly, the PR-1-type protein identified in
S. scabiei is part of the pathogenome and is conserved in S. ipo-
moeae, further supporting a potential role for this protein in
Streptomyces-plant interactions.
Propionibacterium acnes produces abundant porphyrins,
which might contribute to skin damage (542). The interaction of
porphyrins with oxygen is thought to contribute to keratinocyte
damage and consequently to have implications regarding the
pathogenesis of progressive macular hypomelanosis (543).
Concanamycins are produced by several Streptomyces species,
including S. diastatochromogenes (544), S. neyagawaensis (545), S.
graminofaciens (546), and S. scabiei (547, 548). For instance, con-
canamycins A and B, produced by S. scabiei, exhibit phytotoxic
activity (549) and have been proposed (but not proven) to be
virulence determinants in that organism. It should be noted that
the other concanamycin family members are not produced in S.
acidiscabies or S. turgidiscabies (548–550).
Plant-Actinobacteria beneficial interactions. Actinobacteria
are microorganisms capable of colonizing the rhizosphere
through their antagonistic and competitive characteristics con-
cerning other soilmicroorganisms (503). Like other beneficialmi-
croorganisms, Actinobacteria can affect plant growth in two gen-
eral ways, either directly or indirectly. Indirect promotion occurs
when they prevent the harmful effects of one or more deleterious
microorganisms. This is chiefly done through biocontrol or an-
tagonism toward soil plant pathogens. Specifically, colonization
or the biosynthesis of antibiotics (551) and other secondary me-
tabolites can prevent pathogen invasion and establishment. Direct
promotion of plant growth occurs when the plant is supplied with
a compound that is synthesized by the bacteria, or when the latter
otherwise facilitates plant uptake of soil nutrients. Possible con-
tributions of this sort include nitrogen fixation, siderophore syn-
thesis, phytohormone synthesis, and solubilization of minerals to
make them available for plant uptake and use (552).
(i)Actinobacteria as biological control agents.TheActinobac-
teria are widely recognized for their potential in biocontrol (553–
555) because they are important producers of bioactive com-
pounds (556). Over the past 50 years, there have been many
studies on the mechanisms by which Actinobacteriamight inhibit
pathogens in soil, including antibiosis, nutrient competition, pro-
duction of degradative enzymes, nitrous oxide production, and
quorum quenching (557–559). Their adaptability to different en-
vironments in the rhizosphere makes them a strong competitor.
Some are known for their production of siderophores, which can
chelate iron, depriving other organisms of this important micro-
nutrient (560, 561). Siderophore production by S. griseorubigi-
nouse is effective in the fight against Fusarium wilt of banana
caused by Fusarium oxysporum f. sp. cubenese (561). Actinobacte-
ria have also been reported to secrete enzymes that degrade the
mycelial cell walls of fungal parasites, as described in several stud-
ies (556, 562–565). Several chitinolytic enzymes have been identi-
fied in some species of Actinobacteria, including S. antibioticus
(566), S. aureofaciens (566), S. lividens (567), S. plicatus (568), S.
halsteiiAJ-7 (569), and S. lydicusWYEC108 (570). A biofungicide
containing Streptomyces lydicus WYEC 108 was approved by AG
(Natural Industries Inc., TX, USA) and registered in 2004 as Ac-
tinovate soluble (EPA registration number 73314-1). The prod-
uct, which is completely water soluble, is a biofungicide that effec-
tively protects against and controls many common foliar and
soilborne diseases.
Actinobacteria are also widely known for their ability to pro-
duce antibiotics that allow them to inhibit plant pathogens (556,
571, 572). Trejo-Estrada et al. (564) have shown a correlation
between the production of antibiotics in soil Actinobacteria and
effectiveness in the fight against plant pathogens. For example,
Streptomyces violaceusniger YCED9 produces three antifungal
compounds, including nigrecine, geltanamycine, and guanidylf-
ingine, that fight against plant pathogens (564). Similarly, several
antibiotics produced by Actinobacteria are currently used in bio-
logical control (Table 3).
Millard (573) reported that green manures, or crops grown
specifically for biomass to be incorporated into soil, could reduce
the infection of potatoes by pathogenic Streptomyces scabiei. Later,
in 1926, Sanford (574) noted that Actinomyces scabiei was “very
sensitive to the secreted products of many molds and bacteria,
some of which prevent its growth,” and suggested that green ma-
nures favored the antagonistic bacteria that inhibited the patho-
gen. Subsequently, Millard and Taylor (575) showed that soil in-
oculation with a saprophytic (nonpathogenic) Actinomycete
isolate could significantly reduce both disease (potato scab) and
pathogen populations, concluding that the saprophytic inocu-
lated strain outcompetes the pathogen in soil, thereby reducing
plant disease.
Antibiotic-mediated inhibition of pathogens is generally the
primary focus in efforts to suppress plant diseases. However, the
diversity of secondary metabolites produced by Streptomyces and
other species also offers great potential for suppressing fungal,
bacterial, oomycete, and nematode pathogens.
(ii) Actinobacteria as plant growth-promoting rhizobacteria.
In attempts to develop commercial biocontrol and plant growth-
promoting products using rhizobacteria, it is important to recog-
nize the specific challenges they present. To begin with, the inter-
action between plant growth-promoting rhizobacteria (PGPR)
species and their plant symbionts appears to be specific, even
within a crop or cultivar (552, 576). While a rhizobacterium
screened for growth promotionmay reveal positive effects on one
crop, it may have no effect or even retard the growth of another
(577, 578). Although rhizobacteriamay present unique challenges
to our attempts to harness their beneficial attributes, the prospects
for improving agriculture by using PGPR for biocontrol seem to
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be excellent. The first step toward exploiting PGPR species to en-
hance plant growth will be to better understand the systems that
enable them to act as efficient plant growth enhancers.
Since the 1990s, several nitrogen-fixing Actinobacteria have
been recognized and found to be associated with plants. Coryne-
bacterium sp. AN1 isolated from the plant forest phyllosphere re-
duces acetylene and can be regarded as a substitute for nitroge-
nous fertilizer as a means of promoting maize growth (579).
Pseudonocardia dioxanivorans CB1190 isolates, which can grow
on 1,4-dioxane as their sole source of carbon and energy, have also
been shown to fix dinitrogen (580). Despite the well-documented
history of Streptomyces in biocontrol and preliminary evidence of
their capacity to enhance plant growth (581), the potential of
Streptomyces species as PGPR has not been widely studied. This is
surprising because streptomycetes, which generally account for an
abundant percentage of the soil microflora, are particularly effec-
tive colonizers of plant root systems and are able to endure unfa-
vorable growth conditions by forming spores (582).
Merriman et al. (583) reported the use of Streptomyces griseus
(Krainsky) Waksman and Henrici isolates to treat the seeds of
barley, oat, wheat, and carrot, in order to increase their growth.
The isolate was originally selected for the biological control of the
pathogen Rhizoctonia solani. Though the S. griseus isolate did in-
crease the average grain yield, dry foliage weight, tiller number,
and advanced head emergence for both wheat and oat relative to
controls, the differences were not statistically significant. How-
ever, the isolate was more successful as a seed treatment for car-
rots. Marketable yields were increased over controls by 17% and
15% in two separate field trials. In addition, both trials also pro-
vided an improved yield of large- and very-large-grade carrots
relative to controls (583). Nearly 20 years later, El-Abyad et al.
(584) described the use of three Streptomyces spp. in the control of
bacterial, Fusarium, andVerticilliumwilts, early blight, and bacte-
rial canker of tomato. In addition, tomato growth was signifi-
cantly improved by the use of the antagonistic Streptomyces spp.
for a seed coating. An increased availability of growth regulators
produced by the inoculum was the reason proposed for the im-
provement in tomato growth, although this has not yet been for-
mally tested (584). While studies conducted by El-Abyad et al.
(584) and Merriman et al. (583) reported plant growth enhance-
ment to be a function of the magnitude of inoculation with Strep-
tomyces, but the behavior of the inocula under gnotobiotic condi-
tions and the possible mechanisms of streptomycete-mediated
growth promotion should be investigated further.
(iii) Actinobacteria as symbionts. Streptomyces spp. constitute
protective mutualistic symbioses in which the host feeds and pro-
tects the bacteria and in return the bacteria provide antibiotics to
protect the host, or their resources, from pathogens (585). Other
genera of Actinobacteria, namely, Frankia and Micromonospora,
form mutualistic symbioses with higher organisms via nitrogen-
fixing actinonodules in trees and shrubs (586, 587).
For a long time, diazotrophy in the Actinobacteriawas thought
to be limited to the genus Frankia. However, molecular studies
have increased the number of known nifH-containing Actinobac-
teria beyond Frankia spp. (587–591). The discovery of these acti-
nobaceria has stimulated further discussion and inquiries on the
origin and emergence of diazotrophy among Actinobacteria. Ni-
trogen-fixing Actinobacteria in the genus Frankia live as soil sap-
rophytes and as endophytic symbionts in over 200 plant species
(592). The genus Frankiahas a special significance as the nitrogen-
fixing partner in a symbiosis with certain nonleguminous plants,
most notably of the genera Alnus, Casuarina, and Elaeaginus, per-
mitting these plants to grow well in nitrogen-poor soils. Some
species of higher plants are symbiotic, forming endophytic asso-
ciations with actinomycetes to achieve actinorhizal nitrogen fixa-
tion (168). The genus Frankia establishes a symbiotic relationship
with many flowering plants. The best-known example is the alder
(Alnus), where theseActinobacteria are found in the roots, in nod-
ules where nitrogen gas is allowed to reach the nitrogenase (168).
(iv) Actinobacteria as endophytes. Endophytic Actinobacteria
have been isolated from a wide variety of plants. The most fre-
quently observed species belong to the genera Microbispora, No-
cardia, Micromonospora, and Streptomyces, the most abundant
(566, 593). Unlike pathogenic streptomycetes, endophytic species
persist inside the plant host for long periods of time without caus-
ing observable disorder symptoms and lack known virulence de-
terminants shared with phytopathogenic Streptomyces spp. (503).
Endophytic streptomycetesmay improve the growth of their plant
host by producing auxins that promote root growth and develop-
ment (594, 595). Moreover, endophytic colonization of Pisum sa-
tivum with the endophyte S. lydicus improves the frequency of
root nodulation by Rhizobium spp., causing enhanced iron and
molybdenum assimilation and vigorous plant growth (596).
(v) Actinobacteria as elicitors of plant defense. In addition to
direct toxic effects on othermicrobes, nitrous oxide production by
Streptomyces has been suggested to activate plant defenses, im-
proving the plant’s protection against pathogens (597). Recently,
Mahmoudi et al. (559) reported that streptomycetes can degrade
the signaling compounds that coordinate the expression of genes
required for pathogenicity in Pectobacterium carotovorum, sug-
gesting a further mechanism for disease suppression. In addition,
the production of chitinases or plant growth-promoting com-
pounds has been reported to contribute to disease suppression by
some Streptomyces isolates (598–601).
CONCLUSIONS AND FUTURE PERSPECTIVES
In this review, we have provided a comprehensive overview of the
current knowledge concerning the biology of the phylum Actino-
bacteria and applications of its members in medicine, agriculture,
and industry. Distributed in both terrestrial and aquatic ecosys-
tems, its members play a crucial role in the recycling of refractory
biomaterials. The diversity of this phylum is large and includes
many beneficial but also some pathogenic species.Mycobacterium
tuberculosis is carried by 2 billion people in the world and is the
causative agent of tuberculosis, killing severalmillion people every
year. There are also the scab-causing streptomycetes, which have a
broad host range, infect plants, and are known for their ability to
cause necrotic scab-like lesions on economically important root
and tuber crops, such as potato. On the other hand, the Actino-
bacteria have numerous clear potential benefits for humans as
sources of novel antibiotics, antifungals, anticancer agents, and
other secondary metabolites that might be used in medicine or to
improve plant growth and resistance to diseases. Actinobacteria
are also very promising for biocontrol of pests and as plant growth
promoters.With the rapid developments in the fields of genomics,
synthetic biology, and ecology and the strong requirement for new
antimicrobial compounds to combat antimicrobial resistance, the
biology of theActinobacteria is a highly dynamic research field and
we expect to see many new advances in this field in the years to
come.
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